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Abstract 
Aims: This systematic review aims to evaluate the current evidence base for the use of 
Motivational Interviewing (MI) for individuals with diabetes.   
Methods: A systematic search strategy was undertaken to identify studies which 
investigated the effects of MI on glycaemic control in individuals with diabetes. The articles 
were then screened using a priori inclusion criteria, which resulted in a total of 12 studies 
being included within the review.   
Results: Motivational Interviewing was found to be superior in improving glycaemic control 
than a comparison/control group in some, but not all, of the included studies. In those 
studies which reported beneficial effects of MI, effect sizes ranged from 0.06 to 0.49 which 
would be considered small.   
However, when MI was compared to educational interventions, more favourable results were 
found in the latter group. Indeed, the greatest effect size was reported for structured 
diabetes education (SDE) which demonstrated a larger effect on improving glycaemic control 
compared to a MI intervention.  
Conclusions: The results of this review provide a somewhat mixed picture and at this stage 
it would not appear that MI consistently offers superior outcomes when compared with usual 
care or other comparator approaches. However, this review has highlighted the need to 
explore the application of this approach for individuals aged 18-50 and consider whether 
there are any differences in outcomes for those with type 1 (T1D) or type 2 (T2D) diabetes.  
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Introduction 
Diabetes is a common metabolic condition, which has been estimated to affect 2.9 million 
people within the UK, equating to approximately 4.4% of the overall population [1]. 
Diabetes occurs when the body is either unable to produce insulin (T1D) or is unable to 
effectively use the insulin it generates (T2D). As insulin is required to help the body 
breakdown glucose, this condition can result in individuals experiencing hyperglycaemia 
(raised blood sugar levels), which can over time lead to additional health complications 
including heart disease, stroke, blindness, kidney disease and nerve damage [2]. 
In order to achieve optimal glycaemic control, individuals with T1D must regularly check their 
blood glucose levels, administer insulin injections and monitor their diet and physical activity 
[2]. In contrast, T2D is often associated with obesity [3] and therefore individuals diagnosed 
with T2D are encouraged to reduce their weight, eat a more balanced diet and engage in 
more exercise. In addition, those with T2D diabetes may be required to take insulin 
injections or control their condition with the use of oral medications. Therefore, it is 
necessary to investigate which interventions encourage diabetics to adhere to the lifestyle 
changes that are required to successfully self-manage their diabetes. This is particularly 
important in those who are struggling to control their blood sugar levels who will be at 
greater risk to additional health complications in later life.   
Moreover, research in this area has also highlighted that many individuals with diabetes are 
at increased risk of psychological difficulties [4, 5]. It is therefore important to consider which 
interventions may positively affect individual’s psychological wellbeing and promote 
resilience in the face of this chronic health condition. Hence, national guidelines recommend 
that psychological interventions should be offered to children and adults with T1D and T2D. 
This includes the use of cognitive behavioural therapy (CBT), goal setting skills and 
motivational interviewing (MI) [6]. It has, however, been argued that the evidence for the 
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impact of psychological interventions on diabetes care is limited and further research is 
required [7]. 
Motivational Interviewing has gained increasing interest within the academic and clinical field 
over the past 10 years as a short-term intervention, which could potentially help to improve a 
range of outcomes in individuals diagnosed with diabetes. Motivational Interviewing is 
defined as a “directive method for enhancing intrinsic motivation to change by exploring and 
resolving ambivalence” [8]. There are four key guiding principles that underpin MI: (i) 
express empathy, (ii) roll with resistance, (iii) develop discrepancy and (iv) support self-
efficacy. Alongside these, Miller and Rollnick [8] describe the importance of the MI “spirit” 
which has its roots in Rogerian psychotherapy. The “spirit” consists of three essential 
components which help to guide the therapy: 1) collaborate with and empower the individual 
you are working with, 2) support and respect the individual’s autonomy and their potential to 
solve their own problems, and 3) develop an intrinsic motivation for change by helping to 
elicit change talk from the individual. Motivational Interviewing draws on existing concepts 
and techniques from behaviour change theories including: Cognitive Dissonance theory [9]; 
Self-Perception theory [10] and the Transtheoretical Stages of Change Model [11].  
Since the first clinical description of MI in the 1980s, research and applications of this 
approach have increased rapidly. Whilst MI was initially applied to individuals with alcohol 
problems, it has since been used to address drug abuse, gambling, chronic disease 
management, health related behaviours and eating and anxiety disorders [12]. 
Numerous studies have investigated the efficacy of MI. Hettema et al. [13] conducted a 
meta-analysis across 72 studies which had used MI interventions in the areas of alcohol 
abuse, smoking, HIV/AIDS, drug abuse, treatment compliance, gambling, intimate 
relationships, water purification/safety, eating disorders, diet and exercise. The average 
short-term between-group treatment effect size was 0.77, which diminished over time to 0.30 
with the strongest support found for interventions used in the treatment of alcohol and drug 
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abuse. The authors identified that there was large variability across studies and therefore 
suggested that further research was needed to clarify the specific variables which increase 
or decrease the effectiveness of MI interventions. An additional review which investigated 
the effects of MI for weight loss concluded that the approach was effective in improving diet, 
exercise behaviours, regimen adherence and weight loss in individuals with obesity, pre-
diabetes and T2D [14]. The author, however, emphasised the need for further research to be 
completed in order to determine whether MI performs better as a stand-alone treatment or if 
its effects are greater when combined as an adjunct to other treatment packages.  
 
At the time of writing this review, there have been no published systematic reviews that have 
investigated the effects of MI solely with individuals with diabetes. As there has been a 
number of recent research studies published in this area, it appears timely to collate these 
research findings to determine the likely efficacy of this approach within this population.  
Objectives 
This systematic review aims to evaluate the current evidence base for the use of MI with 
individuals with diabetes.  The review will address a number of key objectives based on the 
Scottish Intercollegiate Guideline Network Guidelines (SIGN, 50) [15]. The review will 
address the following questions: 
 Population: Who are the population being targeted with this approach?  
 Intervention: What is the format, content and duration of the intervention provided?  
Who is providing the MI intervention and what training have they undertaken? 
 Comparators: What is MI being compared to?   
 Outcomes: What outcomes are being measured? Where are the most significant 
changes seen?  
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 Study design: What is the quality of the research being carried out in this area? Are 
there gaps in the research? 
Method 
Data sources and searches 
A systematic search of the literature was completed on the 11 th February 2012. Any further 
literature published after this date was not included within the review.  The following 
databases were systematically searched: OVID Medline (1946-2012), OVID Embase (1974-
2012), CINHAL (1980-2012), PsycINFO (1980-2012), Psychology and Behavioural Sciences 
Collection (1980-2012), Web of Science (1898-2012) and Science Direct (1980-2012).  Text 
word searches were completed using terms relating to diabetes, motivational interviewing 
and intervention studies.  The results of the searches were combined using the Boolean 
operators “AND” and “OR”.   
Inclusion criteria 
All studies identified from the database searches were screened against inclusion and 
exclusion criteria which are presented below.   
Inclusion criteria 
 Diagnosis of diabetes (T1D or T2D) 
 Quantitative  research design 
 Use of “motivational interviewing” within the title or abstract 
 Intervention studies where motivational interviewing was compared with a control 
group or another intervention approach  
 Studies which recorded a measure of glycaemic control as one of the outcomes 
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 Studies published in English  
Exclusion criteria 
 Research not published in English 
 Qualitative research studies 
 Studies where not all participants have a diagnosis of diabetes 
 Studies which report only baseline data 
 Study protocols 
 Studies relating to the prevention of diabetes 
 Studies that do not report a measure of glycaemic control as an outcome measure 
Data extraction and quality assessment 
Data was extracted for all the studies which met inclusion criteria using a data extraction 
form (Appendix 1.2). These studies were then rated using a quality assessment tool 
(Appendix 1.3).  The tool was constructed using recognised quality guidelines: Consolidated 
Standards of Reporting Trials (CONSORT) [16], SIGN 50 guidelines [15] and Downs and 
Black [17].  The tool consists of five sections: aims/objectives, introduction, methods, results 
and discussion. Following quality rating, studies were coded as Good (>75%), Moderate (50-
75%) or Poor (<50%).  
Fifty percent of the studies were randomly selected for independent review by another 
researcher using the same checklist. There was 100% agreement between raters for the 
assignment of papers to quality rating categories.  
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Results of search strategy  
The search generated a total of 294 articles. The titles and abstracts of each of these were 
reviewed against the inclusion criteria. After removing articles that did not meet the inclusion 
criteria, a total of 51 articles remained. Following this, duplicates were removed leaving a 
total of 28 articles for review. Of the 28 articles accessed in full, a total of 13 articles met full 
inclusion criteria and underwent quality rating [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 
30]. Subsequently, one article was excluded after it received an overall rating of “poor” by 
both the author and the independent rater [24] leaving a total of 12 articles.  Figure 1 
illustrates the outcome of the search process. 
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Figure 1: Flow chart of review process and study inclusion/exclusion criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Databases searched using terms relating to 
diabetes mellitus, motivational interviewing and 
intervention studies 
 Medline 
 Embase 
 CINHAL 
 PsycINFO 
 Psychology and Behavioural Sciences 
 Wed of Science 
 Science Direct 
TOTAL N = 294 
 
After examination of titles and abstracts numbers 
remaining for further review 
N=51 
Full text copies accessed. Articles examined using 
full inclusion/exclusion criteria 
N=28 
Studies which were quality rated  
N=13 
Review of title and abstracts: 
Excluded if not an intervention 
study or does not explicitly 
include diagnosed diabetes 
patients. Qualitative studies also 
excluded at this stage 
Duplicate articles removed 
 
Studies which did not meet full 
inclusion/exclusion criteria 
excluded. Studies which did not 
have a control group, provided 
pilot data only or did not report 
a measure of glycaemic control 
were excluded at this stage. 
Studies included in Systematic review 
N=12 
Studies which received a “poor” 
quality rating confirmed by an 
independent rater were 
excluded 
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Quality of included studies 
Of the remaining 12 studies, 50% were rated as high quality [19, 21, 22, 23, 25, 30] and 50% 
were rated as moderate quality [18, 20, 26, 27, 28, 29].  
Results 
Description of included studies 
The characteristics of the studies included in the review are displayed within Table 1 as 
recommended by the Higgins et al. [31]. 
[Insert Table 1 here] 
Population 
Age 
Of the 12 studies included within this review, nine evaluated the effect of an MI intervention 
for adults over the age of 50 [18, 19, 22, 23, 25, 26, 27, 29, 30] whilst the remaining three 
studies considered the effects of MI for adolescents [20, 21, 28].   
Type of diabetes 
Seven of the 12 articles involved participants with a diagnosis of T2D [19, 22 23, 26, 27, 29, 
30]; two studies included participants with T1D [21, 28] and one study used participants with 
a diagnosis of both T1D and T2D [25].  The two remaining studies did not specify the 
diagnosis of the participants within their study [18, 20]. 
Gender 
Eight of the studies included both male and female participants [19, 21, 22, 23, 25, 26, 28, 
29], whilst two studies included only women in their samples [27, 30]. Two of the published 
studies did not specify the gender of the participants included [18, 20].  
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Ethnicity  
Fifty percent of the studies reported the ethnicity of the participants in their sample [21, 22, 
27, 28, 29, 30]. In five of these studies the highest ethnic group represented was Caucasian, 
followed by Black and Hispanic [21, 27, 28, 29, 30]. Within the additional study, participants 
from Black ethnic origin made up the majority of the sample [22]. The remaining articles did 
not report the ethnicity of the participant’s within their study [18, 19, 20, 23, 25, 26]. 
Country from which research was conducted  
Five of the included articles were conducted in the United States of America [22, 27, 28, 29, 
30], two were carried out in the UK [20, 21] two in Denmark [25, 26], two in Holland [18, 23] 
and the remaining study was completed in Taiwan [19].  
Intervention 
Study design  
Eleven of the included studies were randomised controlled trials whilst the remaining article 
was a pilot pre-post intervention study [20]. 
Duration 
There was a considerable variation in the number of MI sessions offered and the duration of 
each session. This ranged from a one-off session of up to 60 min [19] to a total of 15 
sessions lasting approximately 15 min each, over a period of six months [22]. In many of the 
studies it was difficult to ascertain the exact number and duration of the MI sessions that 
were delivered [18, 20, 21, 27, 28]. Within two of the studies the authors allowed the 
participants to decide on the frequency and location of appointments. The average number 
of sessions for both of these studies was four with a range between one and nine contacts 
[20, 21]. An additional study outlined the number of sessions offered to their intervention 
group however, did not outline the duration of these contacts [27]. Within two of the studies, 
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the authors reported that participants received a different number of contacts with the health 
professional but did not appear to account for this in the results [18, 28]. Overall, the number 
and duration of the MI session offered varied considerably both between and within the 
studies.  
MI deliverers 
The MI interventions were facilitated by a range of professionals including nurses, dietitians, 
physiotherapists, psychologists, general practitioners (GPs), diabetes educators and 
researchers.  Four of the studies exclusively used nurses as facilitators [19, 21, 22, 23], two 
studies used clinical psychologists [27, 30], two were led by diabetes educators [28, 29], one 
by dietitians [18], one by GPs [26], one by a researcher [20] and the remaining study used a 
range of health care professionals to deliver the MI intervention [25].   
MI protocol 
Three of the studies reported the use of a treatment protocol for the MI intervention [25, 28, 
29]. Six studies did not specify using a treatment protocol [18, 19, 20, 21, 27]  and the 
remaining three studies indicated that a protocol may have been followed, however no 
specific details were provided which would allow replication [22, 23, 30]. 
MI training 
Seven of the 12 studies provided clear details on what training the MI facilitators had 
undertaken [18, 20, 23, 25, 26, 28, 29].  The remaining five studies reported the profession 
of the MI interventionist, however, it was unclear what specific training they had undertaken 
[19, 21, 22, 27, 30]. 
The training received by the MI interventionists varied somewhat between the studies. The 
most common duration of training received was two days with a variety of follow-up support 
being offered. This support was provided in the form of individual supervision, peer support, 
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group conference calls and skill refresher sessions. The maximum duration of training was 
reported to be five days theoretical training followed by three practical coaching sessions, 
every three months for 18 months [25]. 
Treatment fidelity 
Nine of the research studies reported the way in which treatment fidelity was measured [18, 
20, 21, 22, 23, 25, 28, 29, 30]. Four of these studies utilised the MI Treatment Integrity 
System (MITI), which is a behavioural coding system designed to measure treatment fidelity 
for MI [18, 25, 28, 29].  The other studies described audio recording a selection of the 
therapy sessions and providing either oral or written feedback via supervision or an external 
trainer.  
The remaining three studies did not report how treatment fidelity was measured [19, 26, 27]. 
Indeed, within one of these studies it was reported that there may have been a 
contamination effect between the MI interventionists and the control interventionists and this 
could have influenced the results [26]. 
Confounding variables  
When reviewing the literature it is important to consider any additional confounding variables 
that could have influenced the overall results. In two studies it was observed that participants 
could be referred for additional support if required [19, 25]. The authors acknowledged this 
within the methods section and described briefly what this could involve; either educational 
sessions, peer support through a “diabetes club” or individual counselling in relation to diet, 
smoking, alcohol or exercise [25]. The authors, however, do not take this into account when 
comparing the effects of the MI intervention and the control group.  
Alongside this, another study provided all participants with access to a web-based education 
programme that aimed to support self-management. This was offered to both the 
experimental and control group as a voluntary adjunct to their treatment. The focus of this 
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programme was to support self-reflection, goal-setting problem solving and active patient 
participation [23]. The potential effect this could have had on outcomes for both groups was 
not taken into account during analysis or addressed in discussion.  
Comparators 
How is MI being offered? 
Six of the studies compared MI interventions to treatment as usual (TAU) [18, 19, 20, 23, 25, 
26], which consisted of attending their routine appointments with clinic staff, GPs or dietitians.  
The MI interventions were often included as an adjunct to another form of treatment. For 
example, in Smith et al. [27] and West et al. [30], individuals in both groups participated in a 
group intervention based on a behavioural weight control program. Following this, 
participants either received individual MI sessions (intervention group) or were randomised 
to the control group and received no further intervention.  
Welch et al. [29] compared diabetes self-management education including MI to diabetes 
self-management education alone in order to determine whether the addition of the MI 
sessions would promote better outcomes. Furthermore, Wang et al. [28] compared MI to a 
structured diabetes education programme to determine which approach would be most 
effective for adolescents with T1D.  
The remaining two articles included a comparator group in order to compare the effects of an 
MI intervention to another form of contact with health professionals. Channon et al. [21] 
offered the control group non-directive psychological support, information and education as a 
comparator to the MI intervention.  Hawkins [22] provided videophone contacts on a monthly 
basis to the control group, who were able to discuss six different hand-outs from a healthy 
lifestyle pack.  
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Outcomes 
A summary of the key outcomes in provided within Table 2. 
[Insert Table 2 Here] 
Glycaemic control 
All of the studies included within this review investigated the effect of an MI intervention on 
glycaemic control. This was measured by HbA1c [18, 19, 20, 22, 23, 25, 26, 29], A1C [21, 28, 
30] or %GHb [27]. 
Six of the studies reported better outcomes for glycaemic control for the MI group compared 
to the comparison group [19, 20, 21, 22, 27, 30]. Four of the studies reported no significant 
differences between MI and control groups [18, 23, 25, 26] and two of the studies reported 
more favourable results for the comparator group than for the MI intervention group [28, 29]. 
Of the studies indicating positive outcomes for MI, two compared MI to TAU, [19, 20],  three 
provided contact with a health professional which took the form of discussion of health 
related topics, education/information sharing and overall non-directive support (averaging 5-
6 contacts) [21, 22, 30]. The final study offered both groups a 16 week behavioural weight 
control programme following which the MI group were offered three additional individual 
sessions whilst the control group were not offered any additional intervention [27]. 
It is worth noting that the two studies which showed more favourable results for the control 
group had provided structured diabetes education sessions as the comparator to MI [28, 29].  
This was either diabetes self-management education (DSME) or structured diabetes 
education (SDE).  
 
 
19 
 
Lifestyle/clinical outcomes 
Seven of the 12 studies recorded additional lifestyle/clinical outcomes [18, 22, 23, 25, 26, 27, 
30]. These included body mass index (BMI), waist circumference, cholesterol, blood 
pressure as well as information on saturated fat intake, fruit and vegetable intake and 
physical activity.  
Overall, all of the studies reported that there was no difference between groups for the 
majority of the measures recorded. One of the studies, however, reported that the MI group 
showed a significantly lower saturated fat intake at post-test compared to the control group 
[18]; but another study reported that saturated fat intake was reduced in the control group 
but not in the MI group [23]. Another of the studies reported that the MI group showed 
greater weight loss than controls at each visit [30]; however, both groups showed weight loss 
from baseline to follow-up.   
Psychosocial outcomes 
Eight of the 12 studies also reported psychosocial outcomes following the intervention.  
There were an array of measures used across the studies to consider the effect of MI on 
diabetes-related distress, perceived competence in managing diabetes, fear of 
hypoglycaemia, health locus of control, diabetes-related quality of life, depression, diabetes 
self-care, wellbeing, family behaviours and diabetes knowledge. Up to eight different 
psychosocial measures were used within an individual study [21].  
Two of the studies reported greater improvement in self-efficacy in the MI group compared to 
controls [19, 22]. Further benefits of MI were reported for quality of life (QoL) [19, 21], 
knowledge of diabetes [22], health locus of control [23], reduction in fear of hypoglycaemia 
[20], worry and anxiety [21] and perceived competence in dealing with diabetes [25].  
Whilst there were areas in which the benefits of MI were reported on psychosocial measures, 
a number of studies reported no significant differences between groups for depression, 
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anxiety and stress [19], wellbeing, family behaviours or diabetes knowledge [20] or in 
diabetes-related distress [23, 25].  
No differences were observed between groups in one of the studies [28] who investigated 
the effect of MI on depression, QoL and diabetes self-care activities.  
Effect size 
Effect sizes were calculated for eight of the included studies [18, 19, 20, 21, 22, 27, 28, 30]. 
The remaining four studies did not provide adequate data to enable an effect size calculation 
to be completed [23, 24, 25, 26].  Where beneficial effects of MI were reported, effect sizes 
ranged from 0.06 [20] to 0.49 [22], indicating small effect sizes. In the studies reporting 
superior outcomes for the control group, only one effect size was calculable and was found 
to be 0.67, indicating a moderate effect [28].  
Outcomes defined by diagnosis  
T1D  
Two studies investigated the effects of MI for adolescents with T1D [21, 28]. Channon et al. 
[21] reported positive effects of an MI intervention on glycaemic control when compared to 
non-directive psychological support. These improvements were maintained at 24 months.  In 
addition, significant differences between groups for wellbeing, QoL and anxiety were noted, 
in favour of the MI group.   
In contrast to these promising results for MI, Wang et al. [28] found no differences between 
groups for any of the psychosocial outcomes measured and showed a greater effect of the 
control condition (SDE) on glycaemic control compared to the MI intervention.   
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T2D 
The majority of studies included within this review investigated the effects of MI for 
individuals with T2D.  Seven of the articles specifically included individuals with T2D with a 
mean age between 53 and 66 years. Of these studies, four reported significant 
improvements in glycaemic control in the MI group which were not equalled by the control 
group [19, 22, 27, 30]. Two of the studies were unable to demonstrate any superior 
advantage of MI over the control group [23, 26] and one study demonstrated a greater 
improvement in glycaemic control in the control group compared to the MI group [29].  
T1D and T2D 
Rosenbek-Minet et al. [25] recruited participants with a diagnosis of T1D and T2D to their 
study. Overall, a greater number of individuals with type 2 diabetes were included (78% vs 
22%). The authors reported no superior effect of an MI intervention compared to usual care, 
on measures of glycaemic control, body mass, waist circumference, blood pressure, 
cholesterol or diabetes related distress. The only significant difference was found in relation 
to perceived competence in dealing with diabetes in favour of the MI group at 12 month 
follow-up.  The authors did not analyse the results separately by diagnosis and therefore it is 
unclear whether there was a similar pattern for those with T1D and those with T2D.  
 
Discussion 
Overall findings  
This review aimed to evaluate the current evidence base for the use of MI with individuals 
with diabetes. Overall, a mixed picture emerged. Motivational Interviewing was found to be 
superior in improving glycaemic control than a comparison/control group in some [19, 20, 21, 
22, 27, 30], but not all of the included studies [18, 23, 25, 26, 28, 29]. 
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Of the studies reporting beneficial effects of MI, two provided an MI intervention to 
adolescents with T1D [20, 21] and the other four utilised the approach with adults with T2D 
[19, 22, 27, 30]. The effect size of the improvements of these studies ranged from 0.06 [20] 
to 0.49 [22] which would be considered as small.  
The two studies which compared MI to an educational programme found more favourable 
results for glycaemic control within the latter group [28, 29]. It may be that when compared 
with educational interventions, MI is unable to match the improvements seen within these 
structured approaches. The study which offered an educational intervention either with or 
without MI revealed more positive results for the group who received the educational 
intervention only. Interestingly, the results suggested that adding MI as an adjunct to 
education does not promote better outcomes in this population. Therefore, it may be that 
structured education is a more effective intervention for improving glycaemic control than MI. 
The four studies which were unable to report any superior benefit of MI over the control 
group all compared MI with TAU [18, 23, 25, 26]. The results from these studies would 
suggest that MI offers no significant benefit in helping to improve glycaemic control in 
individuals with diabetes when compared to TAU.  
In addition, the studies included in the review were unable to provide consistent evidence 
that MI could produce positive effects on psychosocial outcomes. Whilst some 
improvements were noted in the areas of self-efficacy [19, 22], QoL [19, 21], knowledge of 
diabetes [22, 23], locus of control [23], fear of hypoglycaemia [20], worry and anxiety [21] 
and competence in dealing with diabetes [25], these improvements were not consistent 
across studies and overall the majority of studies were unable to endorse the benefits of MI 
across the wide range of psychosocial outcomes measured.  
Furthermore, there was little evidence to suggest that the MI approach was beneficial in 
improving lifestyle/clinical outcomes. Although a reduction in saturated fat intake was 
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reported in one study [18], it is widely acknowledged that self-report measures of dietary 
intake are open to bias and therefore the accuracy of this outcome measure should be 
treated with caution.  However, one study was able to demonstrate a greater improvement in 
weight loss in the MI intervention group compared to the control group [30]. 
 
Methodological limitations of the evidence 
Sample size 
Of the studies included within the review, eight had completed a power calculation in order to 
determine sample size [18, 19, 21, 22, 23, 25, 26, 29]. One of these studies was unable to 
recruit sufficient participants which limited the overall conclusions that could be made [25]. 
Without the assurance of having completed a power calculation the results of any 
comparison between groups needs would need to be interpreted with caution.   
Dropout rates 
Participant dropout rates within some of the studies were high (e.g. 35% [18], 26% [29]) and 
although no differences in the dropout rates of the MI and the control group were observed 
[18], this may have impacted on the overall follow-up data. 
Glycaemic control at baseline  
Whilst it would be assumed that MI interventions would be targeting individuals who were 
struggling to manage their diabetes, three of the studies had included participants who had 
adequate or good glycaemic control at baseline [20, 23, 30]. The inclusion of participants 
who were already achieving satisfactory glycaemic control may have made it more difficult to 
observe a change over time. Furthermore, the appropriateness of using MI to target those 
already achieving good control may be questionable.  
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Confounding variables 
As noted within the results section, several studies failed to account for potential 
confounding variables which could have influenced the validity of the results obtained [19, 23, 
25].  The additional support options available to participants in these studies could have 
influenced the outcomes for both the MI and control groups. Therefore, it is difficult to 
conclude that it was solely the MI intervention influencing the outcomes and as a result the 
conclusions from these studies should be interpreted with caution.   
Generalisability 
The question of generalisability of the results remains an issue for consideration. Hawkins 
[22] targeted a specific niche population of older adults living in rural America where the 
majority of the sample were Black women who had been educated to high school level.  
Additionally, two further studies included only women with T2D [27, 30], making it hard to 
generalise the results across genders.  
From the studies reviewed, the participants recruited were either adolescents [20, 21, 28] or 
adults over the age of 50 [18, 19, 22, 23, 25, 26, 27, 29, 30].  Thus little research appears to 
have been conducted on the impact of MI interventions of adults between the age of 18 and 
50 with diabetes.  
Further research in this area would help to provide further information on the impact of  MI 
across the age range.   
Outcome measures 
It is worth noting that many of the research studies utilised a wide range of outcome 
measures in order to attempt to highlight the beneficial effects of MI.  Not only is it more time 
consuming for participants and more difficult to complete the follow-up measures, there is 
also the concern that measures are being used without a clear rationale. 
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Limitations of the review  
The present review used an extensive search strategy to identify all articles relevant to the 
review questions. Strict inclusion criteria were applied and only studies of moderate or high 
quality were included. Unpublished studies and those not written in English were excluded 
and this may therefore be a source of bias. Whilst ideally all of the included studies would 
have been independently quality rated, time constraints meant than only 50% of the articles 
underwent this process.  Furthermore, the inclusion criteria for this review specified that 
studies must have included a measure of glycaemic control both pre- and post- intervention. 
As a result, a number of studies that focused only on psychosocial or additional lifestyle 
factors were excluded.   
Conclusions and directions for future research  
This systematic review aimed to evaluate the efficacy of using MI with individuals with 
diabetes. The results of the review provide a somewhat mixed picture, and at this stage it 
would not appear that MI consistently provides superior outcomes when compared to TAU or 
other treatment approaches. In the studies where MI was shown to be more effective in 
improving glycaemic control, the overall interaction effect sizes were small.  
The results from this review are derived from studies investigating the effect of MI on 
adolescents under the age of 18 and in adults over the age of 50.  There is a gap in the 
research literature with regard to the effects of MI on adults between ages of 18 and 50.  
Further research should consider this population and investigate the effects of the MI 
approach across the age range. There is much evidence of the growing ‘epidemic’ of 
diabetes which is beginning to affect individuals at a far younger age.  A recent report by the 
British Broadcasting Corporation (BBC) indicated that it is younger people who are at most 
risk of long-term complications and stressed the difficulties this could cause for the National 
Health Service (NHS) if appropriate resources are not provided [32]. That being the case, 
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there is a need to focus research on this population in order to ensure that individuals of all 
ages are able to access the most appropriate interventions.  
Whilst the treatment fidelity measures would support the delivery of MI by a range of health 
professionals, it will be important to continue to assess and measure treatment fidelity within 
the research studies in order to ensure that the “spirit” and skill requirements for MI are 
being adhered to. Whilst there is some debate as to how appropriate it is to manualise MI 
[13], there is scope for researchers and practitioners to utilise the MITI, which offers a 
behavioural coding system designed to measure treatment fidelity. In many ways this avoids 
having to create a manual, whilst also being able to claim that what is being offered is truly 
MI.  Further research into the optimal content, duration and support offered in MI training 
would help inform the use of this approach in clinical practice and guide the training of other 
professionals.    
The present review included articles involving participants with T1D and T2D.  The results 
from this review were unable to specifically determine whether MI is more effective in T1D or 
T2D as the results were mixed. It would be useful for future research to consider whether 
there are any differences in the outcomes between these populations when other factors are 
controlled for.   
Many of the studies utilised a wide range of questionnaires and collected a vast number of 
outcome measures. Whilst this can be useful in the first instance to try to identify where the 
effect of MI might lie, there is a need to identify which outcome measures are most likely to 
demonstrate the benefits of MI within this population. Furthermore, it is important that the 
researchers take into account these multiple comparisons and control for these in their 
statistical analysis.  
In the light of recent government policies and service redesign, there is a move towards 
increasing access to psychological therapies [33]. Motivational Interviewing appears to be an 
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approach that is being adopted by a range of health professionals as a way to explore 
ambivalence and improve motivation in their patients with diabetes. As with any 
psychological approach, it is important that those delivering the intervention are provided 
with sufficient training and supervision to ensure that patients are being offered the most 
effective treatments. In addition, high quality research is required to tease out the active 
components of the approach and enhance our understanding of how MI should be 
implemented. However, Miller and Rollnick [34] express their concerns about the ways in 
which the approach has been open to ‘reinvention’ which has at times led to the therapy 
being offered in a way that no longer resembles the true essence of MI. They emphasise the 
need for a clear professional consensus on the boundaries and competencies of MI in order 
to ensure that patients are receiving the highest quality of care [34]. Further research in this 
area is required in order to address these concerns.  
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Table 1. Description of studies included in the review 
 
 
Authors Design 
Participants 
 
Intervention 
 Comparator 
group 
Outcomes 
Sample Age (M) 
 
Gender 
 
 
Content Duration 
Delivery 
method 
Deliverer 
Brug et al. 
(2007) 
RCT Diagnosis 
not 
reported 
 
n = 142 
59 Not 
reported 
 3-4 counselling 
sessions in MI 
1 x 45 min with 
additional 15 
min sessions 
 
INDV Dieticians Usual care 
3-4 counselling 
sessions with 
dietician not 
trained in MI 
HbA1c 
Saturated fat intake 
Vegetable intake 
Fruit intake 
BMI 
WC 
 
Channon 
et al. 
(2003) 
Pilot 
intervention 
study 
Diagnosis 
not 
reported 
 
n = 22 
16 Not 
reported 
 Content of MI 
sessions: 
Awareness 
building 
Alternatives 
Problem solving 
Making choices 
Goal setting 
Avoidance of 
confrontation 
Participants 
decided on 
location and 
frequency of 
appointments 
over 6 month 
intervention 
phases. 
Mean number of 
visits (5) 
 
INDV Researcher Usual care 
Did not receive 
MI intervention 
HbA1c 
Wellbeing 
Diabetes knowledge 
Self-care behaviours 
Personal model of 
diabetes 
Family processes 
Management of 
diabetes in the family 
Channon 
et al.  
(2007) 
Multicentre 
RCT 
T 1D 
 
n = 66 
15 (I) 
 
15 (C) 
47% M 
 
50% M 
 “Menu of 
strategies” to 
elicit patient 
views and 
explore 
discrepancies 
between beliefs 
and behaviour 
Frequency and 
location decided 
by participant 
over 1 year 
(20-60 min) 
Mean number of 
visits = 4 
INDV Nurse 
training in 
health 
psychology 
Non directive 
psychological 
support, 
information and 
education 
(every 6-8wks) 
Mean number of 
visits =  6 
A1C 
Diabetes QoL 
Locus of control 
Autonomy 
Diabetes knowledge 
Self-efficacy 
Wellbeing 
Family behaviour 
Personal models of 
diabetes 
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Table 1 Continued… 
Authors 
 Design 
Participants 
 
Intervention 
 Comparator 
group 
Outcomes 
Sample Age  
 
Gender 
 
 
Content Duration 
Delivery 
method 
Deliverer 
Chen et al. 
(2011) 
RCT T 2D 
 
n = 215 
59 50% M  MI intervention 
(Miller and 
Rollnick, 6 stage 
process) 
45-60 min 
session x 1 
INDV Nurses Usual care HbA1c 
Self-management 
Self-efficacy 
QoL 
Depression/anxiety/ 
stress 
 
Hawkins 
(2010) 
 
RCT 
 
T2D 
 
n = 66 
 
64 (I) 
 
66 (C) 
 
 
5%  M 
 
4% M 
  
Structured using 
the Diabetes 
self-
management 
support 
intervention 
guide (DSMS) 
 
Wkly 15 min x 
12 wks 
Monthly 15 min 
x 3 months 
Total 6 months 
(15 sessions) 
 
INDV via 
phone 
 
Nurses 
 
Attention 
control: 
Contacted 
monthly to 
discuss one of 
the 6 hand-outs 
from healthy 
lifestyle pack 
 
 
HbA1c 
Diabetes knowledge 
Self-efficacy 
Clinical parameters 
 
 
Heinrich et 
al. (2010) 
 
RCT T2D 
 
n = 584 
59 55% M  MI counselling 
intervention 
designed to fit 
to diabetes care 
consultations. 
In addition, able 
to access web 
based education 
programme 
 
Quarterly 
consultations x 
20 min over 2yr 
 
INDV Nurses Usual care with 
nurse who did 
not attend MI 
training. 
In addition, able 
to access web 
based education 
programme 
HbA1c 
Self-management 
behaviours 
Clinical parameters 
Autonomy 
Health care climate 
Health locus of control 
Diabetes-specific QoL 
Diabetes related distress 
Rosenbek 
Minet et 
al. (2011) 
 
 
RCT 
 
 
T1D 
&T2D 
 
n = 298 
 
 
57 (I) 
56 (C) 
 
52% M 
 
 
49% M 
 
 
 MI programme 
Semi-structured 
interview format 
of MI specifically 
developed for 
this intervention 
programme 
5 counselling 
sessions lasting 
45 min each at 
1,3,6,9 and 12 
months 
 
 
INDV Range of 
health care 
professions 
 
Usual care 
Routine check-
up at GP x 4 per 
year 
HbA1c 
Diabetes related distress 
Clinical parameters 
Perceived competence 
for diabetes 
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Table 1 Continued... 
Authors Design 
Participants 
 
Intervention 
 Comparator 
group 
Outcomes 
Sample Mean age  
 
Gender 
 
 
Content Duration 
Delivery 
method 
Deliverer 
 
Rubak et 
al. (2011) 
 
 
 
RCT 
 
 
T2D 
 
n = 628 
61 
 
 
58% M 
 
 
 Consultations 
with a GP 
trained in MI 
 
Up to 3 
consultations 
per patient up to 
45 min each 
(mean 1.5) 
INDV 
 
GP trained 
in MI 
 
Usual care 
Up to 3 
consultations a 
year with a GP 
not trained in MI 
 
HbA1c 
Diabetes self-care 
Physical activity 
Clinical parameters 
 
Smith et al. 
(1997) 
 
 
 
RCT 
Pilot study 
T2D 
 
n = 22 
62 0% M 
 
 16 weekly group 
meetings 
(behavioural 
weight control 
programme) 
plus 3 individual 
MI sessions 
 
3 sessions 
(1 beginning and 
2 mid 
treatment) 
Mixed Psych 16 weekly group 
meetings 
(behavioural 
weight control 
programme)-no 
MI sessions 
 
GHb 
BMI 
Treatment adherence 
 
 
 
 
Wang et al. 
(2010) 
 
RCT T1D 
 
n = 44 
15 (I) 
 
16 (C) 
 
9% M 
 
 
13% M 
 Manulised MI 
intervention-
limited details 
on what this 
involved 
2 intervention 
sessions 
(enrolment and 
3-4 months 
later) 
Phone F/U were 
scheduled for 1 
and 2 month 
with 
3rd session 
scheduled if A1c 
remained > 9% 
 
GROUP Diabetes 
educators 
 
 SDE 
 
Medication 
Monitoring 
Acute 
complications 
Lifestyle 
A1C 
QoL 
Depression 
Diabetes self-care 
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Table 1 Continued... 
Authors Design 
Participants 
 
Intervention 
 Comparator 
group 
Outcomes 
Sample Mean age  
 
Gender 
 
 
Content Duration 
Delivery 
method 
Deliverer 
 
Welch et 
al. (2010) 
 
 
 
RCT 
 
T2D 
 
n = 234 
 
56 
 
41% M 
  
MI intervention 
protocol 
combining MI 
and DSME 
 
4 sessions over 6 
months 
1 x 60 min 
3 x 30 min 
 
INDV 
 
Diabetes 
educators 
 
DSME x 4 sessions 
over 6 months 
1 x 60min 
3 x 30min 
 
HbA1c 
Diabetes related distress 
Self-care 
Diabetes treatment 
satisfaction 
Depression 
Self-efficacy 
 
West et al. 
(2007) 
 
 
RCT 
 
 
T2D 
 
n = 217 
 
 
53 
 
0% M 
 
  
All received an 
18 month group 
based 
behavioural 
obesity 
treatment and 
then  
randomised to 
MI group, 
Individual 
sessions (x5) 
 
 
18 month group 
based obesity 
treatment (42 
sessions) 
plus 
5 x 45 min 
sessions of MI or 
control 
 
 
INDV 
 
 
Clinical 
Psych 
 
 
All received an 18 
months group 
based 
behavioural 
obesity 
programme then 
randomised to 
Attention control 
group: Individual 
health education 
sessions (x5) 
 
A1C 
BMI 
Treatment Adherence 
 
 
 
 
 
 
 
M = male; I = intervention; C = control; RCT = randomised control trial; INDV = individual; BMI = body mass index; QoL = quality of life; T1D = type 1 diabetes mellitus; T2D = type 2 
diabetes mellitus; MI = motivational interviewing; GP = general practitioner; SDE = structured diabetes education; CBGT = Cognitive behaviour group training; DSME = diabetes self-
management education; GHb /A1C /HbA1c = Glycated Haemoglobin; F/U = Follow up; WC = waist circumference 
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Table 2 Outcomes of Intervention studies 
Authors Quality rating 
Outcome measures 
Summary of key findings 
Effect 
size Glycaemic control  
 
Lifestyle/clinical 
measures 
Psychosocial 
outcomes 
Brug et al. (2007) Moderate 
 
 
Both MI and CG improved 
HbA1c from baseline-post-
test 
 
No sig. group effect  
 
BMI, WC and 
saturated fat intake 
improved for both 
groups from baseline 
to post-test 
 
MI group sig. lower sat 
fat intake at post-test 
than CG 
_ MI group showed larger changes in 
their saturated fat scores than the CG 
 
No evidence that MI training resulted 
in larger changes in BMI, Glycaemic 
control, WC or fruit intake than the CG 
(usual care) 
 
d= 0.21 
 
Channon et al. 
(2003) 
 
 
Moderate 
 
Sig. improvement in HbA1c 
scores for MI group. 
 
No sig. improvement in 
HbA1c scores for CG 
 
_ 
 
MI group showed sig. reduction in 
fear of hypoglycaemia and rated 
their diabetes as easier to live with 
 
No sig. changes on measures of 
wellbeing, diabetes self-care, 
family behaviours, family process 
or diabetes knowledge 
 
 
MI may be useful in helping 
adolescents with T1D to improve 
glycaemic control and reduce their fear 
of hypoglycaemia. In addition, MI may 
help adolescents to perceive their 
diabetes as easier to live with 
 
d=0.06 
Channon et al. 
(2007) 
 
 
Good Sig. difference between MI 
group and CG in A1c scores 
which were maintained 12 
months after completing 
intervention (in favour of 
MI group) 
_ Sig. difference between groups for 
wellbeing, QoL and personal 
models of illness after 12 months.  
At 24 months sig. differences 
between two groups for life worry 
and anxiety (in favour of MI) 
 
MI may be effective in working with 
teenagers with T1D, producing 
improvements in glycaemic control, 
psychological wellbeing and QoL 
d=0.27 
Chen (2011) Good 
 
 
 
Sig. change in MI group but 
not in CG for HbA1c from 
baseline to 3 month F/U. 
MI improved HbA1c for 
individuals with a baseline 
greater than 7.62 
_ Sig. difference in self-efficacy and 
QoL in MI group but not in CG at 3 
month F/U. 
Both groups scores for depression, 
anxiety and stress decreased. No 
sig. difference between groups at 
3month F/U.  
MI can produce improvements in 
patients with T2D in relation to 
glycaemic control, self-efficacy and 
QoL when compared to usual care 
d=0.18 
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Table 2 Continued... 
Authors Quality rating 
Outcome measures 
Summary of key findings 
Effect 
size 
Glycaemic control (HbA1C) 
Lifestyle/clinical 
measures 
Psychosocial 
outcomes 
Hawkins (2010) Good Sig. change in HbA1c from 
pre-post for MI group but 
not for CG  
No sig. differences 
between groups for 
blood pressure, lipid 
panel or BMI 
Both groups increased their 
knowledge about diabetes (only 
sig. in MI group) 
Sig. improvement in MI group for 
self-efficacy. No such improvement 
seen in CG.  
 
The use of a videophone MI self-
management intervention for older 
adults with T2D sig. improved 
measures of glycaemic control, 
diabetes knowledge and self-efficacy. 
d=0.49 
Heinrich et al. 
(2010) 
 
 
Good No effects of MI group on 
HbA1c measurements 
Fat intake improved in 
CG but not MI group 
 
No effect on veg or 
fruit intake, physical 
activity, weigh or 
blood pressure 
Sig. improvement in health locus of 
control and diabetes knowledge in 
MI group but not in CG 
No advantageous effect of MI 
intervention for glycaemic control, 
weight, blood pressure or self-reported 
measures of fruit and veg intake and 
physical activity. The MI group 
however did show improvements in 
locus of control and knowledge. 
_ 
 
       
Rosenbek Minet et 
al. (2011) 
 
 
Good 
 
 
 
 
No sig. difference between 
MI group and CG in change 
in HbA1c at 12 or 24 month 
F/U. 
No sig. differences in 
weight, cholesterol, 
WC or blood pressure 
between MI group and 
CG 
MI group showed sig. higher levels 
of perceived competence in dealing 
with diabetes at 12 months F/U 
compared to CG. However, this was 
not sustained at 24 month 
 
No sig. difference in diabetes 
related distress scores 
No sig. changes were reported in 
HbA1c, diabetes distress or perceived 
competence in dealing with diabetes at 
24 months F/U. In addition, no sig 
difference was found between groups 
for clinical measures of weight, 
cholesterol or WC, blood pressure. 
Authors are unable to demonstrate 
any benefit of MI over and above usual 
care 
_ 
 
Rubak et al. (2011) 
 
 
 
Moderate 
 
 
 
 
 
Sig. improvement seen in 
both groups from 0 to 12 
months. No sig. difference 
between groups 
 
Improvements in both 
groups for BP, blood 
lipid measurements 
and BMI  
 
_ 
 
Both groups showed improvements 
across a range of clinical and lifestyle 
measurements. There was however no 
sig. benefit of MI over usual care 
within this sample 
 
_ 
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Table 2 Continued... 
Authors Quality rating 
Outcome measures 
Summary of key findings 
Effect 
size 
Glycaemic control (HbA1C) 
Lifestyle/clinical 
measures 
Psychosocial 
outcomes 
Smith et al. (1997) 
 
 
 
Moderate MI group showed sig. better 
glycaemic control than CG 
following intervention 
Both groups lost 
weight-no sig. 
difference between 
groups 
_ The addition of MI to a standard 
behavioural weight control program 
may enhance glycaemic control in 
patients with T2 
d=0.42 
 
Wang et al. (2010) 
 
 
 
Moderate 
 
At 6 months F/U the CG 
(SDE) had lower A1c than 
MI group 
 
_  
There were no differences between 
the groups on any of the 
psychosocial outcomes measured.  
No improvements were seen in 
either group  
 
Structured diabetes education was 
effective in improving metabolic 
control in adolescents with T1D. The 
MI education group did not improve 
metabolic control. Neither group 
positively influenced psychosocial 
outcomes 
 
 
d=0.67 
Welch et al. (2010) Moderate 
 
 
Sig. changes in HbA1c were 
observed in both the MI 
group and the CG 
Those receiving MI had a 
sig. lower change score than 
those in the CG 
 
_ None of the factors examined as 
potential mediators (depression, 
treatment satisfaction or 
perceptions of importance and self-
efficacy regarding target self-care 
behaviours) were shown to affect 
HbA1c 
The MI intervention was not found to 
be associated with improvements in 
HbA1c when compared to the non-MI 
condition.  Mean change in glycaemic 
control was sig. better for the CG than 
the MI group 
 
 
 
  _ 
West et al.  
(2007) 
Good 
 
 
 
 
 
 
Glycaemic control improved 
in both MI group and CG 
(attention control) at 6 and 
12 months. However, 
improvements not 
sustained at 18 months. Sig 
difference between groups 
in favour of MI 
Both groups lost 
weight from baseline 
to F/U.  MI group lost 
sig. more weight than 
CG at each visit 
_ MI as a brief adjunct intervention sig. 
enhanced both weight loss and 
glycaemic control in overweight 
women with T2D 
d=0.09 
CG = control group; MI = motivational interviewing; F/U = follow-up; HbA1c/A1c = Glycated Hemoglobin, SDE = Structured Diabetes Education; QoL = quality of life; WC = waist 
circumference; T1D = type 1 diabetes mellitus; T2D = type 2 diabetes mellitus; BP = blood pressure 
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LAY SUMMARY 
Individuals with type 1 diabetes (T1D) have a number of important daily tasks they must 
complete in order to manage their condition. This can include checking blood glucose levels, 
administering insulin and monitoring diet and physical activity. For adolescents with diabetes 
this can be a particularly challenging task. 
An innovative approach based on “narrative therapy” has been used within this research 
study. Two individuals aged 19 and 27 who had previously struggled to control their diabetes 
were invited to meet with adolescents aged 12 and 15 years old who were currently 
struggling to manage their condition. We referred to these young adults as “experienced 
patients” as they have first-hand experience of what it is like to live with T1D. 
Whilst there are a number of challenges in engaging with adolescents with T1D, this 
therapeutic group did appear to be a positive addition to usual care. Feedback from follow-
up interviews suggested that taking part in the group had been a positive experience for 
participants, helping them to feel less isolated and more motivated to manage their condition.  
The experienced patients also reported that the group had been beneficial in helping them to 
reflect on their own experiences of having diabetes. However, no significant improvements 
were observed for more formal measures including average blood glucose over time, 
diabetes-related distress and self-efficacy.   
Further research with a larger number of participants is required in order to draw more 
conclusive findings on this approach for adolescents with T1D.  
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ABSTRACT  
Objectives: This study aimed to investigate the feasibility and acceptability of a narrative 
therapy group approach for adolescents with type 1 diabetes (T1D).  
Design: The study employed a between-group, repeated measure design comparing a 
narrative therapy group intervention to a control group who received treatment-as-usual.   
Methods: 75 adolescents aged between 12 and 15 years old who had been identified as 
having poorly controlled T1D (HbA1c > 8%), were invited to participate in a one-off narrative 
therapy group. A total of eight individuals agreed to take part and were randomly allocated to 
either the intervention group (n=4) or treatment-as-usual (n=4). Information on the 
acceptability of this approach was gathered from follow-up interviews three months after 
attendance at the group. Outcome measures included HbA1c, diabetes-related distress and 
self-efficacy. 
Results: The adolescents who did attend the intervention group reported it to have been a 
beneficial experience which had helped them to feel less isolated in their experience of living 
with diabetes. Additionally, some participants reported that the group had provided them with 
a ‘wake-up’ call and had encouraged them to re-think the way they manage their condition. 
However, no significant changes in HbA1c, diabetes-related distress or self-efficacy were 
observed in either the intervention or the control group at three month follow-up.   
Conclusions:  This novel group approach was considered to be an acceptable adjunct to 
treatment-as-usual. All adolescents who attended the group reported that they would 
recommend it to other young people with T1D.  A larger scaled study would be required in 
order to determine whether this approach can improve glycaemic control and psychosocial 
outcomes in an adolescent population.  
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INTRODUCTION 
Diabetes in adolescence 
It has been estimated that approximately 25,000 individuals in the UK under the age of 25 
are living with type 1 diabetes (T1D) (Diabetes UK, 2010). This condition can be extremely 
difficult to manage as patients must learn how to maintain the balance between insulin 
dosage, diet and activity (Waller, 2004). Furthermore, during adolescence, metabolic control 
often worsens and if not addressed, can lead to significant long-term health consequences 
(Dabadghao et al., 2001). During the transition from childhood to adolescence, peer 
relationships become central to the individual’s sense of identity. For those with a diagnosis 
of diabetes, the restrictions placed upon them by their condition can impact on their sense of 
belonging within a peer group and as a result some will go on to neglect health regimes and 
self-care in favour of peer group acceptance (Kyngas et al., 1998). 
Current psychological treatment of diabetes 
Individuals with T1D are typically managed within an outpatient setting where they receive 
input from a medical consultant, specialist nurse and a dietitian (Hampson et al., 2001). In 
addition to the medical management of diabetes, there are recommendations that 
educational and psychosocial interventions should also be offered as an integral part of 
diabetes care (Gage et al., 2004).  
A systematic review of educational and psychosocial interventions with adolescents with 
T1D was undertaken by Hampson et al. (2001). A total of 62 studies were included for 
evaluation, of which 25 were randomised controlled trials. Effect sizes were calculated from 
14 of these studies and indicated a small to medium effect. The authors emphasised the 
importance of targeting individuals with poorly controlled diabetes as a way to reduce 
hospitalisations and future complications (Hampson et al., 2001). 
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Expert patients 
In 2001, the Department of Health (DoH) published a document entitled “The expert patient: 
a new approach to chronic disease management for the 21st century”. The concept of ‘expert 
patient’ is based on the assumption that individuals affected by chronic illness are likely to 
develop expertise in managing their condition and this expertise will differ in nature to the 
knowledge of health care professionals (Wilson et al., 2007). 
One key example of how this policy was put into practice was through the development of 
the Expert Patient Programme (EPP). This was set up in order to help reduce severity of 
symptoms and improve confidence, resourcefulness and self-efficacy of those living with 
chronic illness (Tattersall, 2002). These programmes are facilitated by trained educators who 
have their own personal experience of living with the chronic health condition. 
Evaluation of the EPP reported that patients showed moderate gains in self-efficacy, and 
improvements in quality of life (QoL) and psychological wellbeing (Kennedy, 2007). 
However, the EPP was criticised as it appeared to be attracting those patients who were 
already good self-managers and was failing to reach those patients who might benefit the 
most (Kennedy, 2007). 
Narrative therapy approaches 
In recent years, patient education programmes targeting self-management in diabetes and 
other chronic diseases have undergone considerable changes. There is a growing belief that 
adopting healthy habits depends less on information and skills and more on personal 
intrinsic motivation to make and sustain changes (Piana et al., 2010). Therefore, it is 
important to think of creative and alternative ways to engage with adolescents with T1D in 
order to increase motivation and improve diabetic control.  
One psychological approach that is gaining both academic and clinical accolade is that of 
narrative therapy. This approach emphasises that people are experts in their own lives. It 
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acknowledges that as humans we are always seeking ways of interpreting our world and in 
doing this, we create stories about ourselves and others. These stories then often influence 
the way we lead our lives. Narrative therapists believe that hearing the way in which a 
person tells their story can provide valuable information about how that individual makes 
sense of their situation and how they decide to live their life (Morgan, 2000).  
As part of this approach, ‘outsider witnesses’ are sometimes invited to listen to therapeutic 
conversations.  Outsider witnesses may or may not be known to the individual and will vary 
in their level of knowledge and experience in relation to the therapeutic issue being 
addressed. The outsider witness role is to listen to the individual’s ‘preferred stories’ or ‘ways 
of living’ and help to reflect on what they hear.  
Narrative therapy approaches have been utilised in previous research studies with 
adolescents with T1D. For example, Piana et al. (2010) evaluated the effects of a narrative-
autobiographical approach for adolescents with T1D. Ninety four adolescents with T1D 
attended a nine day summer camp and participated in structured daily writing sessions on 
diabetes which was integrated with daily interactive self-management education. Follow-up 
questionnaires revealed that writing about diabetes had been a very liberating experience 
and helped the adolescents to overcome their feelings of isolation and increase their self -
efficacy and acceptance of living with diabetes (Piana et al., 2010). However, follow-up data 
was only obtained from approximately 50% of the adolescents who attended the summer 
camp. This raises questions about the generalisability of the results as it is possible that 
those that who had a more favourable experience were more motivated to return their 
questionnaires. As a result, some of the more negative perspectives on the therapeutic 
approach may have remained undetected. In addition, no control group was utilised within 
this study which makes it difficult to determine whether it was the intervention approach per-
se that influenced outcomes or whether there were other factors that were instrumental in 
eliciting change.  
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Background and rationale for present study 
A novel group approach drawing on narrative therapy was undertaken at the University 
College London Hospital. Adolescents who were patients within an inpatient setting and who 
were presenting with symptoms of pain and fatigue were recruited (Christie et al., 2010). The 
authors piloted a one-off workshop lasting approximately two hours. In total, eight 
participants were recruited; four were current patients on the ward and the remaining four 
were individuals who had previously been inpatients but who were now managing to cope 
with their symptoms more effectively. These individuals were known as ‘experienced 
consultants’ and were included within the group to act as outsider witnesses. The four 
experienced consultants had personal experience of what it is like to struggle with the 
challenges facing the current inpatients and had ‘expert’ knowledge about how to tackle 
many of the difficulties the adolescents were facing.  
The findings from this small project reported positive outcomes for the adolescents within the 
inpatient ward, including progress in managing their physical symptoms and a positive 
change in attitude towards their current difficulties (Christie et al., 2010). 
AIMS/OBJECTIVES 
The present study therefore aims to replicate this narrative therapy group approach with 
adolescents with a diagnosis of T1D. The primary objective of this research study was to 
assess the feasibility of conducting a larger controlled trial and to determine whether the 
group was considered to be an acceptable addition to treatment-as-usual (TAU) for 
adolescents with T1D. Specifically the pilot study aimed to: 
1. Assess if a larger research study would be warranted 
2. Inform the design of future studies in terms of the “PICO” requirements outlined by the 
Scottish Intercollegiate Guidelines Network (SIGN 50, 2011). 
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a) Target Population: Confirm the eligibility and suitability of individuals who are likely to 
benefit from the treatment 
b) Intervention: Identify any modifications required to the narrative therapy group 
approach 
c) Control group: Provide detailed information on what TAU involves 
d) Outcomes: Confirm which outcomes may be appropriate to target in future 
interventions 
RESEARCH QUESTIONS 
Primary questions 
1. What are the potential numbers of participants who fulfil eligibility criteria and what 
proportion of these individuals consent to take part in this narrative therapy group? 
2. Do participants within the narrative therapy group report the intervention to be an 
acceptable addition to TAU and what modifications may be required for future 
interventions? 
Secondary questions 
1. Does participation in the narrative therapy group have an effect on HbA1c levels at 
three month follow-up? 
2. Does participation in the narrative therapy group reduce diabetes-related distress at 
three month follow-up?  
3. Does participation in the narrative therapy group increase self-efficacy at three month 
follow-up?  
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METHODS 
Study design 
The study employed a between-group, mixed method, repeated measure design. Using a 
stratified random sampling approach based on gender, participants were allocated to either 
the intervention or control group.  Allocation to groups was independently conducted using a 
computerised random number generator.  
Study participants  
Participants  
Patients were invited to take part in the research study if they were aged between 12 and 15 
and had had a diagnosis of T1D for at least one year.  In addition, inclusion criteria specified 
that individuals required an HbA1c measure of > 8% at their last two clinic appointments. 
Furthermore, patients were excluded from the study if: they had a known learning disability, 
English was not their first language and/or they were currently receiving psychological input 
from the Paediatric Psychology team.    
Experienced patients 
In consultation with the medical and research team, it was decided that the individuals who 
would attend the group as outsider witnesses would be referred to as “experienced patients”. 
This differs slightly to the terminology used by Christie et al. (2010), however when 
consulted, the medical team felt that this would be the most appropriate term to adopt within 
this setting.  
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Ethical considerations 
Ethical approval was granted from the West of Scotland Ethics Committee on the 
29/11/2011 (Appendix 2.2) and was supported by the local NHS Research and Development 
Department. 
Recruitment  
Participants 
After gaining ethical approval, information sheets were sent to those who met the inclusion 
criteria (Appendix 2.3) and their parent/guardian (Appendix 2.4). Potential participants were 
asked to complete an opt-in form (Appendix 2.5) which indicated their interest in participating 
in the research study.  Following this, participants were randomly allocated to either the 
intervention group or control group and consent forms were completed by both the 
adolescent (Appendix 2.6) and their parent/guardian (Appendix 2.7). Following the 
intervention, participants were asked if they would be willing to provide further information 
about their experiences of attending the group by taking part in a follow-up interview. Again 
further consent was obtained from the participants and their parent/guardian.  
Experienced patients 
Diabetes Consultants identified and approached patients who were aged 17 and over who 
had previously struggled to manage their diabetes but whom were now showing 
improvement in their diabetes management. These patients were invited to attend the group 
as experienced patients.  Potential experienced patients were given an information sheet 
(Appendix 2.8) on the research study and were asked to complete an opt-in form (Appendix 
2.9) if they were interested in becoming involved; alternatively they were invited to express 
interest to the Consultant who would then pass on their details to the research team. Once 
interest had been expressed, the experienced patients were invited to sign a consent form 
(Appendix 2.10) to confirm that they wished to participate in the group.  
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Description of intervention approach  
Intervention group 
The intervention group were asked to attend a one-off narrative therapy group at the hospital 
which they would usually attend for their clinic appointments. In total, four participants and 
two experienced patients attended the group. The group lasted two hours and was facilitated 
in accordance with White’s (2003; 2007) recommendations on involving outsider witnesses 
within therapeutic interactions. A brief outline of the format and structure of the group is 
provided below.  
Key stages in involving outsider witnesses within therapeutic interventions: 
 The ‘telling’ of the significant story by each person in the group 
 The ‘retelling’ of each story by the experienced patients who were invited to 
participate as outsider witnesses 
 The ‘retelling’ of the outsider witnesses ‘retelling’ by the adolescents in the group 
 
The process of ‘retelling’ involves four key stages: (1) identifying the expression, (2) 
describing the image, (3) embodying response and (4) acknowledging transport. This was 
facilitated by the Trainee Clinical Psychologist and Clinical Psychologist throughout the 
group. A brief description of this is provided below. 
1. Expression 
The individual is asked to speak about what they have heard that they were most drawn to, 
what caught their attention and captured their imagination.  
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2. Focus on the Image 
They are then asked to describe an image or mental picture that came to their mind as they 
listened to the stories reflecting on the individual’s values, beliefs, hopes, aspirations, 
dreams and commitments.  
3. Personal Resonance 
The outsider witness is encouraged to provide an account of why they were so drawn to 
certain expressions with a specific focus on their understanding of the way these 
expressions struck a chord with their own personal history.  
4. Transport 
The outsider witness is encouraged to speak of the ways in which they have been influenced 
by having listened to the adolescent’s stories.  
Control group 
Individuals who were randomised to the control group continued to receive regular quarterly 
clinic review appointments with the medical team.  
Outcome measures 
Primary outcome measures 
Glycaemic control   
Glycaemic control was assessed from participants' glycated haemoglobin levels (HbA1c) 
which measures average blood glucose concentration over the past 8-12 weeks.  For most 
people with diabetes, the HbA1c target is below 48 mmol.mol-1 or (6.5%). Evidence suggests 
that a score of 6.5% or lower can reduce the risk of developing diabetic complications, such 
as nerve damage, eye disease, kidney disease and heart disease (Diabetes UK, 2012). 
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Secondary outcome measures 
Diabetes-related distress  
Diabetes-related distress was measured using the “Problem Areas in Diabetes-Teen 
Version” (PAID-T), Weissberg-Benchell et al. (2011) (Appendix 2.11). Evaluation of the 
psychometric qualities of this questionnaire has produced satisfactory findings (Weissberg-
Benchell et al., 2011). Respondents are required to answer 26 statements using a 6 point 
likert scale for each ranging from 1 (not a problem) to 6 (a serious problem). A total distress 
score is computed by summing the responses, to provide a score between 26 and 156. 
Higher scores indicate that the adolescent is experiencing more diabetes-related emotional 
distress.  
Self-efficacy  
Self-efficacy was measured using the “Self Efficacy for Diabetes Scale” (Stanford Patient 
Education Research Centre), (Appendix 2.12). This short 8 point questionnaire was used to 
record individual’s perceptions of their self-efficacy in relation to managing their diabetes. 
Investigation of the psychometric properties of this scale has reported high levels of internal 
consistency suggesting that the scale is a reliable measure (Stanford Education Research 
Centre).  Respondents are asked to rate their level of confidence in managing diabetes 
related tasks on a 10 point likert scale, ranging from 1 (not at all confident) to 10 (totally 
confident). A total self-efficacy score is computed by summing the total responses. Higher 
scores indicate a higher level of self-efficacy in relation to managing their diabetes.  
Data collection  
Outcome measures were collected from participants at two time points: baseline and three- 
month follow-up. Following randomisation, all participants were sent two questionnaires to 
their home address and were asked to complete them and then return them to the 
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researcher using the stamped addressed envelope provided. This process was again 
completed three months after the intervention group.  
Additionally, consent was gained from all participants to access their HbA1c scores from two 
clinic appointments prior to the intervention group and two clinic appointments after the 
intervention. This information was collected at their routine clinic appointments and was 
passed onto the researcher from a member of the medical team. Where possible all four 
records of HbA1c were accessed and an average pre-intervention and post-intervention 
score was calculated. For some participants however, only one HbA1c measure post-
intervention was available.  
Data analysis 
The quantitative data, including HbA1c, diabetes-related distress and self-efficacy were 
analysed using Predictive Analytics SoftWare (PASW for Windows, version 18.0, SPP Inc., 
Chicago). As the assumptions of normality were violated in the data set, non-parametric 
analysis was completed. Mann Whitney U-tests were completed for all outcome measures. 
Unless otherwise stated, data is reported as median (interquartile range; IQR). Data from the 
semi-structured interviews was analysed using content analysis as outlined by Bowling 
(2009) and Elo et al. (2007).  Content Analysis has been defined as a method of analysing 
written, verbal or visual communication messages (Cole, 1988). This approach allows 
researchers to condense words into fewer content-related categories as a means of 
describing and quantifying phenomena (Krippendorff, 1980, Elo et al., 2007).   
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RESULTS 
Figure 1. Participant flow diagram 
      
Total population with T1D 
assessed for eligibility  
(n = 189) 
      
            
                    
      Total population who met 
inclusion criteria and were sent 
information packs  
(n = 75) 
      
            
                    
      
Participants who agree to 
participate in the research study 
and were subsequently 
randomised  
(n = 9) 
      
            
                    
                    
Allocated to intervention group  
(n = 4) 
    
 
 
Allocated to control group (n = 5) 
    
Withdrew from study after 
allocation (n = 1) 
                    
Lost to follow-up 
(n = 0) 
    
Lost to follow-up 
(n =0 ) 
    
                    
 
Included in the final analysis by 
measure:   
 
HbA1c (n = 4) 
PAID-T (n = 4) 
Self-efficacy (n = 4) 
Acceptability interview (n = 4) 
 
    Included in final analysis by 
measure: 
 
HbA1c (n = 4) 
PAID-T (n = 4) 
Self-efficacy (n = 4) 
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Demographics  
Table 1. Characteristics of adolescent participants (Mean ± SD) 
Demographic Information Intervention Group Control Group 
Gender (% male) 50 50 
Age (yrs) 15.6 ± 0.8 14.0 ± 1.6 
Duration of Diabetes (yrs) 8.5 ± 4.4 7.7 ± 2.2 
Baseline HbA1c (%) 9.2 ± 1.1 8.4 ± 0.3 
 
Table 2. Characteristics of Experienced Patients  
Demographic Information Experienced Patient 1 Experienced Patient 2 
Gender  Female Male 
Age (yrs) 27 19 
Duration of Diabetes (yrs) 16 19 
 
Feasibility 
Participants 
A total of 75 individuals aged between 12 and 15 who were identified as having poorly 
controlled T1D (HbA1c >8%) were invited to participate in the research study. Of the 75 
contacted, only nine returned the opt-in forms or made contact with the nursing team to 
express an interest in becoming involved (Figure 1). Following randomisation one of the 
participants in the control group decided that they no longer wished to be involved in the 
research and were therefore withdrawn from the study.   
 
56 
 
Experienced patients 
Central to this intervention approach was the recruitment of experienced patients. Contact 
was made with three Diabetes Consultants working across Glasgow to select participants 
that met the inclusion criteria. Initial feedback provided from the Consultants suggested that 
those who were currently managing their diabetes well, had always done so, and those who 
struggled in the past were still struggling or were experiencing additional complications. 
Therefore, the initial inclusion criteria for experienced patients were deemed too stringent 
and instead “individuals who had previously struggled to manage their diabetes but who 
have made improvements over the past year” were identified.  In total, two experienced 
patients were contacted by the primary researcher and both agreed to participate in the 
group. 
Acceptability 
Analysis of participant feedback 
Participants were asked to provide feedback on the experience of attending the therapeutic 
group at three month follow-up by participating in a semi-structured interview (Appendix 
2.14).  Experienced patients also provided written feedback on their experience of the group. 
The information from these sources has been divided into three sub sections: 1) participant 
experiences of the group 2) feedback from the experienced patients 3) considerations for 
future studies. Within each of these categories the main themes from the analysis are 
discussed.  
1) Participant experiences  
The main themes to emerge from the analysis of the interview transcripts with the 
adolescent participants included: i) feeling less isolated; ii) a wake-up call; iii) different kind of 
experience and iv) feelings of relief. 
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i) Feeling less isolated 
One of the most prominent themes to emerge was that of feeling less isolated after attending 
the group. All four participants stated that this was one of the most significant aspects of the 
group.   
“Hearing each individual story and just knowing you are not alone and just knowing 
that there is someone else out there, because sometimes you can feel isolated, it 
was just good hearing everyone’s stories”   
 (Participant 1, P1, L14) 
 
“I am the only one with diabetes [in my house] so I am the only one who has 
experience in this but it was different sitting in the group where everyone had 
experience of the same thing and just made me realise that I wasn’t alone”  
(Participant 2, P2, L29) 
ii) A wake-up call  
For some of the participants, the group made them rethink the way in which they managed 
their diabetes. The group allowed participants to hear other people’s stories and consider the 
potential consequences of not managing their diabetes appropriately.  
 
“I was quite shocked as they let it get so bad and they put themselves in danger, I 
didn’t want to do that so it kind of made me wisen up”  
(Participant 1, P2, L21) 
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 “I have started to take more blood tests and just look after it a bit better… I kind of 
realised you have to take care of it [diabetes]”  
(Participant 3, P2, L20) 
In addition, one participant felt that the group reinforced the idea that diabetes is not going to 
go away and that there is the need to face the issues instead of trying to ignore them.  
“It proved it doesn’t just go away so you need to just kind of accept it, which is a big 
issue I have got”  
(Participant 2, P2, L32) 
iii) Different kind of experience  
Participants reported that the group was a very new experience for them and differed 
considerably from their usual clinic contacts.  
“Although they treat it everyday [doctors and nurses] they don’t know what you go 
through so it is nice hearing people who are going through the same thing”  
(Participant 1, P3, L60) 
 
“It was nothing like I expected, I didn’t really expect it to be much, I had been to see a 
psychologist at Yorkhill before and so I thought it was just going to be like that but it 
was a lot different” 
 (Participant 2, P1, L8) 
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iv) Feelings of relief 
The experienced patients appeared to have provided a sense of relief to participants who felt 
encouraged to hear that diabetes had not prevented them from doing what they wanted in 
life and that it is possible to live with the ups and downs of diabetes. 
 
“It just kind of gave you a bit of relief that they have been through what I am going 
through and have come out the other end, like they are well…it hadn’t stopped her 
doing what she [experienced patient 1]  wanted to do and she is still getting on with 
things whilst keeping her diabetes at bay” 
 (Participant 2, P3, L48) 
 
“It was good; it felt like… because they still have problems [experienced patients] it 
shows that we won’t be the only ones that are going to live with problems”  
(Participant 4, P2, L34) 
2) Feedback from experienced patients  
The experienced patients were asked to provide written feedback on their experiences of 
participating in the group. Following analysis of their comments, the main themes to emerge 
were i) greater reflection; ii) novel therapeutic approach and iii) challenging the feeling of 
isolation. 
i) Greater reflection 
Both experienced patients reported that the group had provided them with the opportunity to 
think about and reflect on their own experiences of having diabetes.  
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 “It brought quite a lot back to me from my own experiences growing up with type 1; I 
felt I could really empathise with the young people”  
(Experienced patient 1, P1, L2) 
“It allowed me to reflect on my diabetes in a way that I normally wouldn’t’”  
(Experienced patient 2, P1, L8) 
ii) Novel therapeutic approach  
The format of the group was discussed by one experienced patient who felt that the 
structured approach allowed each participant to have a chance to reflect on their own 
journey through diabetes and consider their goals and hopes for the future. 
 
“I thought it was a good idea to have each of them come up and answer the 
structured questions they were asked, it got them all to think about how their 
condition really does affect them”  
(Experienced patient 1, P1, L7) 
iii) Challenging the feelings of isolation  
The feeling of isolation was discussed by the experienced patients within the group; they 
acknowledged that they have felt alone in their condition in the past but felt that the group 
provided the participants the opportunity to share their experiences and hear from others in a 
way that lead to a reduction in the feeling of being isolated.  
“I think the isolation is a major one that most young people with type 1 feel at some 
point. This had a major effect on me when I was young and I know how hard it is” 
 (Experienced patient 1, P1, L12) 
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“I feel as the afternoon wore on, the kids began to open up and realised they were 
not alone in the problems they were facing and that there is always someone who’s 
done it and seen it all before” 
 (Experienced patient 2, P1, L11) 
3) Considerations for future 
Within the interviews, participants were asked about ways in which the group could be 
improved or modified in the future. The following three issues were discussed: i) length of 
the group; ii) age of the experienced patients and iii) barriers to participation. 
i) Length of the group 
The majority of participants felt that they would have benefited from additional groups or a 
longer session in order to hear more from others with T1D to be able to share more of their 
own experiences. Additionally, there appeared to be some enthusiasm for attending further 
sessions if they were to be offered.  
“It wasn’t really that long and if it was longer there would have had more time to talk” 
 (Participant 4, P2, L48) 
“It would have been better to have it over a couple of weeks because you would have 
got to talk to the people more” 
(Participant 3, P2, L23) 
ii) Age of the experienced patients 
When asked about how old they felt the experienced patients should be, the majority of 
participants felt that age was not an issue and that older individuals would still be able to talk 
about their experiences and have a useful contribution to make.  
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“It is about experience and I am pretty sure that everyone has similar experiences so 
it wouldn’t really matter”  
(Participant 2, P3, L59) 
“I don’t think there would be any age that was too old”  
(Participant 4, P2, L38) 
It should be noted however, that one participant felt it was important that the experienced 
patients were younger in age to ensure that they would be able to relate to their stories and 
experiences.  
“They should be at least under 25 because you can relate to them easier”  
(Participant 3, P2, L29) 
iii) Barriers to participation  
The reluctance of adolescents to talk about their experiences was highlighted alongside the 
tendency of some young people to use avoidance strategies.   
“For me, one of my problems is that I hate talking about diabetes so that was one of 
my biggest, not fears, but nervous things, so I like to try and shut it out rather than 
talk  about it…I think a lot of people with diabetes are quite similar and would rather 
just not speak about it”  
(Participant 2, P4, L74)  
“Ask a teenager to talk about himself and he talks about stuff like what he has done 
with his pals and nothing to do with his diabetes”  
(Participant 4, P3, L57) 
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OUTCOME MEASURES 
Whilst a statistical assessment of normality would have been preferable, it has been 
acknowledged that such analysis may not be sufficiently sensitive in such small sample 
sizes and therefore a visual inspection of the data was completed (Lund Research Ltd, 
2012). As the data appeared to violate the assumption of normality, non-parametric analysis 
was favoured.  
A Mann Whitney U-test revealed no significant differences between the intervention and 
control group at baseline for HbA1c (Z= -1.59, P= 0.11), diabetes related distress (Z= -0.28, 
P= 0.88) or self-efficacy (Z= -0.43, P= 0.68). 
Primary outcome measure: HbA1c 
The median (IQR) for HbA1c in the intervention group were 8.9 (8.6-9.5) and 9.1 (8.3-10.0) 
for pre- and post- intervention, respectively. In addition, the median (IQR) for the control 
group were 8.4 (8.1-8.6) and 8.4 (7.9-8.8) for pre- and post- intervention, respectively 
(Figure 2). 
 
Figure 2. Median (IQR) HbA1c (%) scores for pre- (  ) and post- (  ) intervention 
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A Mann Whitney U-test revealed that there was no statistically significant difference in 
change scores between groups from pre- to post- intervention (Z = -0.14, p =0.88).  
 
Secondary outcome measure: Diabetes-related distress 
The median (IQR) for diabetes-related distress in the intervention group were 59.5 (51.2-
70.2) and 57.0 (52.2-64.5) from pre- to post- intervention, respectively. Additionally, the 
median (IQR) for the control group were 57.5 (40.3-80.7) and 59.5  (45.5-70.0) from pre- to 
post- intervention, respectively (Figure 3). 
 
 
Figure 3. Median (IQR) PAID-T scores (AU) for pre- (  ) and post- (  ) intervention 
A Mann Whitney U-test revealed that there was no significant difference in the change 
scores between groups from pre- to post- intervention (Z = -0.29, p= 0.88).  
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Secondary outcome measure: Self-efficacy 
Median (IQR) for Self-efficacy in the intervention group were 74.5 (70.2-77.7) and 70.0 
(54.2-78.5) for pre- to post- intervention respectively. The median (IQR) for the control group 
were 72.5 (66.5-75.5) and 71.5 (69.7-74.7) for pre- to post- intervention, respectively (Figure 
4).  
 
Figure 4. Median (IQR) Self-efficacy scores (AU) for pre- (  ) and post- (   ) intervention 
A Mann Whitney U-test revealed that there was no significant difference in change scores 
between the groups from pre- to post- intervention (Z=-0.86, P=0.48). 
Graphs displaying the individual scores for all participants are displayed within appendix 
2.13. 
DISCUSSION 
The primary aim of this pilot study was to investigate the feasibility and acceptability of a 
narrative therapy group approach for adolescents with T1D. Experienced patients were 
recruited to participate in a one-off group to share their experiences of living with diabetes 
and to reflect on the stories of other participants within the group. The structured approach 
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was based upon White’s (2002; 2007) recommendations on involving outsider witnesses 
within therapeutic interventions.  
The secondary aim of this study was to consider whether participation in the group 
intervention had any influence on participants HbA1c or their self-reported measures of 
diabetes-related distress and self-efficacy.  
Summary of main findings 
Feasibility  
This pilot study raised some questions about the feasibility of running similar groups in the 
future. The number of adolescents who agreed to take part in the study was below what had 
been anticipated by the research team. That said, approximately 10% of the total population 
who met inclusion criteria were recruited suggesting that this would be a more realistic target 
for future studies. Additionally, it was difficult to identify suitable experienced patients who 
had previously struggled to manage their condition but who had made significant changes to 
their diabetes self-care.  Whilst the two individuals who were approached to act as 
experienced patients agreed to attend the group, it may be unrealistic to ask them to do this 
on a regular basis without being reimbursed for their time.  
Acceptability 
The results from this study provide evidence that the narrative therapy group approach was 
an acceptable adjunct to TAU. Participants reported that the group had helped them to feel 
less isolated and provided a sense of relief as to what living with diabetes means for them 
and their future. Such findings have also been noted within other research studies which 
have employed a group approach for adolescents with T1D (Due-Christensen et al., 2012; 
Greco et al., 2001; Graue et al., 2005; Piana et al., 2010;; Waller et al., 2005). Furthermore, 
participants reported that hearing other people’s experiences of living with diabetes had 
provided a wake-up call and encouraged them to rethink their own approach to managing 
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their condition. In addition, whilst some of the adolescents were initially reluctant about 
attending a group intervention, high levels of satisfaction were reported by all participants at 
the follow-up interviews.  
Group interventions have been considered as a cost-effective approach with the potential to 
influence psychosocial outcomes and glycaemic control (Greco et al., 2001; Van der Ven, 
2003), however barriers to group participation have also been addressed in previous 
research studies (Christie et al., 2008).  
Outcomes 
There were no significant improvements for either the intervention group or the control group 
for HbA1c, diabetes-related distress or self-efficacy at three month follow-up.  
Study limitations 
There are a number of limitations that should be considered when interpreting the results of 
this study. The number of participants recruited was small and below what was expected. 
Whilst this does provide valuable information on the feasibility of running similar groups, the 
acceptability and outcome data should be interpreted with some caution. Additionally, all 
participants were recruited from one hospital in Glasgow and as a result it may be difficult to 
generalise the findings across regions.  
The group session was not audio or video recorded and no measure of treatment fidelity was 
used. Unlike some other approaches, such as Cognitive Behavioural Therapy (CBT) and 
Motivational Interviewing (MI), there are no standardised treatment fidelity checklists that 
have been created in order to assess adherence to this narrative therapy approach. In order 
to mitigate the effects of this limitation, the group was co-facilitated by a qualified Clinical 
Psychologist with experience in this approach and the group was highly structured around 
the guidelines offered by White et al. (2002; 2007). 
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Follow-up interviews proved invaluable as they provided further information on the 
acceptability of the approach.  It is possible however that the answers provided by 
participants may have been biased as they could have felt the need to provide socially 
acceptable answers. That said, the interview was framed as an opportunity to provide 
information on both the strengths and limitations of the experience in order to help improve 
the intervention for adolescents in the future, and as a result, the participants did appear to 
be open in their responses. In the future it may be useful to utilise a brief social desirability 
questionnaire such as Hays (1989) to determine whether this may have influenced 
participant’s responses. 
Implications for clinical practice and future research  
The present research study provides information on the feasibility and acceptability of this 
narrative therapy group approach for adolescents with T1D.  Drawing on the PICO 
framework (SIGN 50, 2011), the following considerations may be helpful for researchers in 
the future.  
Population 
It seems realistic to question the feasibility of running similar groups in the future due to the 
small number of adolescents who agreed to participate. As indicated in the follow-up 
interviews, adolescents are often reluctant to participate in group sessions and therefore 
ways in which to increase motivation and promote the value of such an intervention should 
be considered prior to running a similar intervention in the future.  Additionally, the criteria for 
recruitment of experienced patients may need some consideration in order to widen the 
scope of potential participants.  
Intervention  
The intervention itself was deemed to be an acceptable adjunct to treatment-as-usual by all 
participants in the intervention group. All participants reported that they would recommend 
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the group to other adolescents. Many participants felt that they would benefit from additional 
sessions and therefore it may be useful to consider running the groups over a couple of 
weeks to consider if further intervention would produce greater improvement in outcome 
measures.  
Control group 
Within this study, those allocated to the control group continued to receive TAU. It may be 
useful for future studies to add a third prong to the research design and compare the 
narrative therapy group to another form of psychological intervention alongside a control 
group. This would help to determine whether any benefits seen in the narrative therapy 
group would be unique to the approach and would help to explore the acceptability of this 
approach compared to another intervention.  
Outcomes 
The use of HbA1c as a measure of glycaemic control would appear to be an appropriate 
outcome measure to use within any future studies. HbA1c is routinely collected for all 
individuals with T1D and therefore the accessibility of such scores and the validity of the 
results would support its application within future research studies.   
Additionally the PAID-T has been validated for an adolescent population and therefore its 
use in future studies would be recommended.  
Within this study, self- efficacy was measured through the “Self Efficacy for Diabetes Scale” 
(Stanford Patient Research Education Centre). As this questionnaire contained only eight 
questions it was considered to be a short and therefore accessible questionnaire to use with 
this population.  Whilst a high level of internal consistency has been reported for this 
measure, it is still awaiting full validation. Indeed, it was interesting to note than many 
adolescents rated themselves as “totally confident” for a majority of the questions. Taking 
into account these individuals were recruited due to their difficulties in managing their 
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diabetes, this finding is somewhat intriguing. It may be that this measure is not sensitive to 
an adolescent’s lifestyle and therefore it may not have tapped into relevant areas for this 
population. Alternatively, it may be that the adolescents recruited within this study may lack 
insight into their difficulties. It would be interesting to explore this in more detail in future 
research considering the role of self-efficacy in adolescents with diabetes.   
 
CONCLUSIONS 
The number of participants recruited in this study was small which raises some questions 
about the feasibility of conducting a larger scaled research study, particularly if adolescents 
are reluctant to attend similar group sessions.  Creative ways to increase motivation and to 
encourage adolescents to attend such groups may be required.  
In relation to outcome measures, no significant changes were found in measures of HbA1c, 
diabetes-related distress or self-efficacy following attendance at the group. This may suggest 
that this one-off group session may not have been sufficient in order to change the way in 
which the adolescents manage their diabetes.   
Those who did attend the group reported it to be a positive experience that they would 
recommend to other adolescents with T1D. Furthermore, all participants acknowledged that 
the group had helped them to feel less isolated in managing their condition. Additionally, the 
experienced patients reported that the group had been a positive experience whereby they 
had been encouraged to reflect on their own diabetes in a way they may not have otherwise.   
Further research utilising a larger sample size would be required in order to support the 
preliminary findings of this pilot study.  
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Abstract 
This reflective account focuses on my experiences of working within a Community Paediatric 
Service. The account describes both my personal and professional development over the 
course of my training, drawing on my experiences of working with one family undergoing an 
assessment for autism.  I consider the wider role of Psychology and in particular, reflect on 
the unique skills and knowledge that Clinical Psychologists can offer in helping to 
understand complex behaviours.  
The account is structured using the model of reflection by Boud, Keogh and Walker (1985) 
which outlines three key phases of reflection: returning to the experience, reflective 
processes and outcomes and action. The model places great emphasis on the importance of 
affective learning and the need to recapture the emotions present at the time of experience 
and reflect on how these may help or hinder the leaning and reflective process.  
Guided by the National Occupational Standards for Psychology (British Psychological 
Society, 2006), I have reflected on my experiences of training and have re-evaluated my 
understanding of what it means to be a competent clinician. I conclude by identifying areas 
for future development and outline my commitment to continue to reflect on my clinical 
practice.  
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Abstract 
Using Kolb’s Learning Cycle (1984) I take the opportunity to reflect on the changing role of a 
Clinical Psychologist using my experience of working within a Child and Adolescent Mental 
Health Service (CAMHS). I explore my own anxieties about joining a team where I initially 
felt that everyone was delivering some form of ‘psychological intervention’ and I reflect on 
how my views of this have changed over the course of the placement. Drawing on current 
policies and relevant research, this account has encouraged me to reflect on the unique 
skills that a Clinical Psychologist can offer to a multidisciplinary team (MDT). Furthermore, 
this account has enabled me to think about my own areas for future development and reflect 
on the way in which I will continue to progress once leaving the security of the doctorate 
course.  
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Does the study have a clearly focused question? 
1.1 1 Yes 
0 No 
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Methods (design) 
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Methods (participants) 
Were the inclusion/exclusion criteria clearly defined? 
3.4 1 Yes 
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Methods (participants) 
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Methods 
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Methods  
Were the outcomes clearly defined?  
3.12 1 Yes 
0 No 
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Methods  
Were the measures used to assess outcomes 
appropriate to the population? 
3.13 1 Yes 
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Results 
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0 No 
Do the conclusions drawn directly link to the results 
achieved?  
5.3 1 Yes 
0 No 
 
Maximum Total Score for RCT = 36; Maximum Total Score for Non RCT = 32 
(75% + Good) (50-75%Moderate) (<50% Poor) 
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Appendix 2.1: Author guidelines (British Journal of Health Psychology) 
The aim of the British Journal of Health Psychology is to provide a forum for high quality 
research relating to health and illness. The scope of the journal includes all areas of health 
psychology across the life span, ranging from experimental and clinical research on 
aetiology and the management of acute and chronic illness, responses to ill-health, 
screening and medical procedures, to research on health behaviour and psychological 
aspects of prevention. Research carried out at the individual, group and community levels is 
welcome, and submissions concerning clinical applications and interventions are particularly 
encouraged.  
The types of paper invited are:  
• papers reporting original empirical investigations;  
• theoretical papers which may be analyses or commentaries on established theories in 
health psychology, or presentations of theoretical innovations;  
• review papers, which should aim to provide systematic overviews, evaluations and 
interpretations of research in a given field of health psychology; and  
• methodological papers dealing with methodological issues of particular relevance to health 
psychology.  
 
1. Circulation  
The circulation of the Journal is worldwide. Papers are invited and encouraged from authors 
throughout the world.  
 
2. Length  
Papers should normally be no more than 5000 words (excluding the abstract, reference list, 
tables and figures), although the Editor retains discretion to publish papers beyond this 
length in cases where the clear and concise expression of the scientific content requires 
greater length.  
 
For full details see:  
 
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2044-
8287/homepage/ForAuthors.htm 
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Appendix 2.2: Ethics approval letters  
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Appendix 2.3: Participant Information Sheet                                                       
Vanessa Watt (Researcher)      
Trainee Clinical Psychologist  
Department of Mental Health and Wellbeing   
Gartnavel Royal Hospital 
Glasgow 
Email: v.watt.1@research.gla.ac.uk 
Telephone: 0141 211 0607 
 
Information Sheet, Version 3 (Participant) 
 
Title: Narrative Therapy Group for Adolescents with Type 1 Diabetes: A Pilot Study 
 
I would like to invite you to take part in my research study. My name is Vanessa Watt and I 
am a Trainee Clinical Psychologist working in the NHS. As part of my training, I am 
completing a research project and I am interested in your experiences of living with Diabetes. 
Before you decide if you would like to take part, it is important that you understand why the 
research is being done and what it will involve.  
 
What is the Research About? 
 
I am planning to run a group for adolescents who have Type 1 Diabetes and who have had 
an HbA1c level of 8 or more over the past 8 months. We know that sometimes attending 
therapeutic groups can be helpful for adolescents and my research is looking to see if this is 
the case for individuals with Diabetes.  
 
The research will involve looking at differences between those who attend a therapeutic 
group and those who continue to receive their normal treatment at the diabetes clinic.  
 
Why have I been asked to take part? 
 
I am interested in involving adolescents aged 12-15 in this study and you have been 
identified by the nursing staff at The Royal Hospital for Sick Children (RHSC) as being 
someone who would meet my criteria.  
 
Do I have to take part? 
 
No you do not have to take part.  
If you did decide to take part, you are allowed to withdraw at any point. 
 
 
What does taking part involve? 
 
 You will be asked to complete the opt-in form provided with this information sheet. 
 
 Once you have opted in to the research you will be contacted by a member of the 
research team and will be asked to complete a consent sheet. Before you fill this in 
you will be given the chance to ask any questions.  
 
 You will be randomly allocated to either the treatment group or the control group. You 
have a 50% chance of being in either group. If you are in the control group, you 
will not attend the narrative therapy group. 
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 Those allocated to the treatment group will be asked to attend a two hour group. This 
will take place between 3 pm and 5 pm at RHSC. The group will also be attended by 
approximately 4 other adolescents and will be run by myself and Dr Liz Hunter, 
Clinical Psychologist. There will also be two older adolescents there who we will refer 
to as “experienced patients”. These are individuals who have previously struggled to 
control their Diabetes but who are now coping better. At least 2 weeks notice will be 
given before the group is due to happen. 
 
 Those within the control group will not be required to attend the group however will 
be asked to complete two questionnaires at roughly the same time as the 
intervention group and then asked to complete the questionnaire again approximately 
3 months later.  
 
 
PLEASE NOTE: You will be asked to attend your routine clinic appointments as usual. 
There will be no disruption to the normal care you receive. If the group is found to be helpful, 
then those in the control group will be offered the treatment once the research study has 
been completed.  
 
What are the possible benefits of taking part? 
 
This is an opportunity to participate in a unique experience. It is possible that there may be 
some benefits of attending the group such as an improvement in how you feel, an increase 
in your confidence in coping with your illness and potentially it may help you to keep your 
HbA1c level within the desired range.  
 
 
What are the possible risks of taking part? 
 
There are no direct risks of taking part although it is possible that the group and/or 
questionnaires may make you think about your diabetes and your ways of coping with this 
illness. If we are worried about your well being, we would ask you if you wanted us to let the 
diabetes team know and further support could be offered to you from the dedicated 
Psychology team at the RHSC. 
 
 
What will happen to the information collected? 
 
All the information collected will remain confidential within the NHS. The results will be 
written up within a report but no names will be included and all information will be 
anonymised. I will send you a short summary of the research findings once the research has 
been completed.  
 
The findings will hopefully help health professionals to provide a better service for people 
who are in a similar position to you.  
 
Who has reviewed the study? 
 
The University of Glasgow and the NHS are both supportive of this research. Approval has 
been gained from the West of Scotland Research Ethics Committee 4. 
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If you have any further questions? 
 
You will be able to keep a copy of this information sheet and you will be able to keep a copy 
of the consent sheet. If you would like more information on the study and wish to speak to 
someone not closely linked to the study please contact Dr Andrew Gumley on 01412110607. 
 
If you are interested in taking part? 
 
If you would be willing to take part in the research, please complete the opt-in form and ask 
your parent/guardian to sign it also. Then please return it in the stamped addressed 
envelope provided (no stamp required).  
 
If you would prefer please contact Gavin Allison, Diabetes Nurse at RHSC and let him know 
that you would be interested in being involved in the research (telephone number: 
01412010331). 
 
Thank you for reading this information sheet  
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Appendix 2.4: Parent/Guardian Information Sheet 
 
 
Information Sheet, Version 3 (Parent/Guardian) 
 
Title: Narrative Therapy Group for Adolescents with Type 1 Diabetes: A Pilot Study 
 
I would like to invite your son/daughter to take part in my research study. My name is 
Vanessa Watt and I am a Trainee Clinical Psychologist working in the NHS. As part of my 
training, I am completing a research project and am interested in your adolescent’s 
experiences of living with diabetes. As your child is under the age of 16 it is important that I 
gain the consent from a parent/guardian as well as from the adolescent themselves.  
 
I have provided some information below relating to my study and have provided my contact 
details for you to get in touch if you have questions about the study.  
 
What is the Research About? 
 
We are running a group for adolescents who have had an HbA1c measure of 8% or more 
over the past 8 months. We know that sometimes participating in educational or 
psychological groups can be helpful for adolescents and my research is looking to see if this 
is the case for those with Type 1 diabetes.  
 
Why has my child been asked to take part? 
 
We would like adolescent’s aged 12-15 to be involved in this study. Your child has been 
identified as meeting the criteria for my research by the nurses who are supporting this 
research. 
 
Does my child have to take part?   
 
No your child does not have to take part in the study. All participation is on a voluntary basis 
and consent can be withdrawn at any point during the project.   
 
 
What will happen next? 
 
 You and your child will be asked to complete the opt-in form provided with this sheet. 
 
 Once the opt-in form has been completed, a member of the research team will 
contact you and both yourself and your child will be asked to complete a consent 
sheet. Before you complete this you will be given the chance to ask any questions.  
 
 Your son/daughter will be randomly allocated to either the treatment group or the 
control group. They will have a 50% chance of being in either group.  If your 
son/daughter is allocated to the control group they will not attend the narrative 
therapy group.  
 
 Those allocated to the treatment group will be asked to attend a two hour group. This 
will take place between 3pm and 5pm at RHSC. The group will also be attended by 
approximately 4 other adolescents and will be run by myself and Dr Liz Hunter, 
Clinical Psychologist. There will also be two older adolescents there who we will refer 
to as “experienced patients”. These are individuals who have previously struggled to 
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control their Diabetes but who are now coping better. At least 2 weeks notice will be 
given before the group is due to happen. 
 
 Those within the control group will not be required to attend the group however will 
be asked to complete two questionnaires at roughly the same time as the treatment 
group and then asked to complete the questionnaire again approximately 3 months 
later.  
 
 PLEASE NOTE: Your son/daughter will be asked to attend their routine clinic 
appointments as usual. There will be no disruption to the normal care they receive. If 
the group is found to be helpful, then those in the control group will be offered the 
treatment once the research study has been completed 
 
What are the possible benefits of taking part? 
 
The group will allow your child to meet with others who also have Type 1 diabetes. They will 
have an opportunity to share their experiences and also to reflect on the experiences of 
others. The group will be based on a psychological approach called Narrative Therapy. This 
approach has been shown to be helpful in helping children and adolescents with chronic 
illness.  
 
What are the possible risks of taking part? 
 
There are no direct risks of taking part however the group may encourage your son/daughter 
to reflect on their experiences of having diabetes and this may be upsetting for them. If we 
are worried about the wellbeing of any participants we would be able to refer them to the 
Psychology Team at RHSC for further support.  
 
What will happen to the information collected? 
 
All the information collected will remain confidential within the NHS. The results will be 
written up within a report however your child’s name will not be added at any point and 
instead all information will be anonymised. I will ensure that a summary of the main findings 
is sent to you following the completion of the research.  
 
Who has reviewed the study? 
 
The University of Glasgow and the NHS are both supportive of this research. Approval has 
been gained from the West of Scotland Ethics Committee 4. 
 
If you have any further questions? 
 
You will be able to keep a copy of this information sheet and you will be able to keep a copy 
of the consent sheet. If you would like more information on the study and wish to speak to 
someone not closely linked to the study please contact Dr Andrew Gumley on 01412110607. 
If you are interested in taking part? 
 
If you would be willing for your son/daughter to take part in the research, please complete 
the opt-in form and return it to the above address.  
 
If you would prefer, please contact Gavin Allison, Diabetes Nurse at RHSC and let him know 
that you would be interested in your son/daughter being involved in the research (telephone 
number: 0141 201 0331). Thank you for reading this information sheet. 
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Appendix 2.5: Participant Opt-in form  
 
OPT-IN FORM, Version 1 (Participant) 
 
Please complete this form if you are interested in being involved in this research study. 
 
Please complete the form below and return it to the above address. If you would prefer, 
please contact Gavin Allison at The Royal Hospital for Sick Children (RHSC) to let us know 
you would be interested in being involved (Telephone Number: 0141201 0331). 
 
I am happy for a member of the research team to contact me by (you can tick more than one) 
 
Telephone                  Please provide telephone number: __________________________ 
 
 
Email    Please provide email address: _____________________________ 
 
 
Letter    
 
Name: _____________________________________________________________ 
 
 
Signature: ___________________________________________________________ 
 
 
Date: _______________________________________________________________ 
 
 
Parent/Guardian Signature: ___________________________________________ 
 
 
Date: ________________________________ 
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Appendix 2.6: Participant Consent Form  
 
 
Consent Form, Version 2 (Participant) 
 
Title: Narrative Therapy Group for Adolescents with Type 1 Diabetes: A Pilot Study 
 
Please initial each box: 
 
I confirm that I have read and understood the participant information sheet for the above 
study and I have been given the opportunity to ask any questions I might have. 
 
I understand that I do not have to take part in this study. It is my choice and I can stop at any 
time, without giving a reason and this will not affect any aspect of my care. 
 
I understand that all information will be confidential and there will be nothing to identify me 
as having taken part in the study. 
 
I agree to the researcher having access to my HbA1c measures from my last two clinic 
appointments and also access to my next two HbA1c measures taken at clinic. 
 
I agree to keep all information discussed within the group confidential. 
 
I agree to take part in the above study. 
 
Name: ________________________________________________________________ 
 
Signature: _____________________________________________________________ 
 
 
Name of Researcher: _____________________________________________________ 
 
Signature of Researcher: __________________________________________________ 
 
Date: ___________________________ 
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Appendix 2.7: Parent/Guardian Consent Form  
 
Consent Form, Version 2 (Parent/Guardian) 
 
Title: Narrative Therapy Group for Adolescents with Type 1 Diabetes: A Pilot Study 
 
Please initial each box: 
 
I confirm that I have read and understood the information sheet for the above study and I 
have been given the opportunity to ask any questions I might have. 
 
I understand that my son/daughter does not have to take part in this study. They will be able 
to withdraw their consent at any time, without giving a reason and this will not affect any 
aspect of their care. 
 
I understand that all information will be confidential and there will be nothing to identify my 
son/daughter as having taken part in the study. 
 
I agree to the researcher having access to my son/daughters HbA1c measures from their 
last two clinic appointments and also for the researcher to have access to their next two 
HbA1c measures which are taken at clinic. 
 
I agree for my son/daughter to take part in the above study. 
 
Name: ___________________________________________________________ 
 
Signature: _________________________________________________________ 
 
 
Name of Researcher: ________________________________________________ 
 
Signature of Researcher: _____________________________________________ 
 
Date: ____________________________ 
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Appendix 2.8: Experienced Patient Information Sheet 
 
Information Sheet, Version 3 (Experienced Patient) 
 
 
Title: Narrative Therapy Group for Adolescents with Type 1 Diabetes: A Pilot Study 
 
I would like to invite you to become involved in my research study. My name is Vanessa 
Watt and I am a Trainee Clinical Psychologist working in the NHS. As part of my training, I 
am completing a research project and I am interested in adolescent’s experiences of living 
with Type 1 diabetes. Before you decide if you would like to take part, it is important that you 
understand why the research is being done and what it will involve.  
 
What is the Research About? 
 
I am planning to run a group for adolescents who have Type 1 diabetes and who have had 
an HbA1c level of 8 % or more over the past 8 months. We know that sometimes attending 
therapeutic groups can be helpful for adolescents and my research is looking to see if this is 
the case for individuals with Diabetes.  
 
The research will involve looking at differences between those who attend a therapeutic 
group and those who continue to receive their normal treatment at the diabetes clinic.  
 
The group will be based on a psychological therapy called Narrative Therapy. It will involve 
sharing your experiences of living with diabetes and reflecting on the experiences of others. 
It will be a structured approach and will be led by myself and a Clinical Psychologist, Dr Liz 
Hunter.    
 
Why have I been asked to take part? 
 
You have been asked to be involved in the research as you have been identified by the 
diabetes nursing team as someone who may have previously had an HbA1c level above 8% 
but who is now managing their condition well. 
 
 
Do I have to take part? 
 
No you do not have to take part.  
If you did decide to take part, you are allowed to withdraw at any point. 
 
 
What does taking part involve? 
 
You will be asked to attend up to 3 different groups, each lasting a total of 2 hours. The 
research team will try to find a time that is suitable for you and will ensure that plenty of 
notice is provided prior to the group starting. 
 
You will be asked to complete a consent sheet prior to the group and will be asked to keep 
all information discussed within the group session confidential. This will mean that you will 
be asked not to talk about the specific details of the group with your friends or family. This 
ensures that all participants feel safe to share their experiences and know that the 
information discussed will not go any further.  
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What are the possible benefits of taking part? 
 
This is an opportunity to be involved in a unique experience. The group may help you to 
reflect on your experiences of living with diabetes and may also encourage you to think 
about the progress you have made over the years.  
 
Your valuable input within this research, may help others to reflect on their experiences and 
may help them to think of alternative ways of coping. 
 
What are the possible risks of taking part? 
 
There are no direct risks of taking part although it is possible that the group may make you 
think about your diabetes and your ways of coping with this illness. If we are worried about 
your well being, we would ask you if you wanted us to let the diabetes team know and further 
support could be offered to you from the Psychology team.  
 
Who has reviewed the study? 
 
The University of Glasgow and the NHS are both supportive of this research. Approval has 
been gained from the West of Scotland Ethics Committee 4.  
 
If you have any further questions? 
 
You will be able to keep a copy of this information sheet and you will be able to keep a copy 
of the consent sheet. If you would like more information on the study and wish to speak to 
someone not closely linked to the study please contact Dr Andrew Gumley on 01412110607. 
 
If you are interested in taking part? 
 
If you would be willing to take part in the research, please complete the opt-in form and 
return it in the stamped addressed envelope provided (no stamp required).  
 
If you would prefer, please contact Gavin Allison at RHSC and let him know you would be 
interested in being involved in the research (telephone number: 0141 201 0331).  
 
Thank you for reading this information sheet  
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Appendix 2.9: Experienced Patient Opt-in form  
 
OPT-IN FORM, Version 1 (Experienced Patient) 
 
Please complete this form if you are interested in being involved in this research study. 
 
Please complete the form below and return it in the stamped addressed envelope provided 
(you do not need to add a stamp). If you would prefer, please contact Gavin Allison, 
Diabetes Nurse at The Royal Hospital for Sick Children (RHSC) to let us know you would be 
interested in being involved (Telephone Number: 0141 201 0331) 
 
I am happy for a member of the research team to contact me by (you can tick more than one) 
 
Telephone      Please provide telephone number: __________________________ 
 
 
Email    Please provide email address: _____________________________ 
 
 
Letter    
 
 
 
Name: _____________________________________________________________ 
 
 
 
Signature: ___________________________________________________________ 
 
 
Date: _______________________________________________________________ 
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Appendix 2.10: Experienced Patient Consent Form  
 
Consent Form, Version 2 (Experienced Patient) 
 
Title: Narrative Therapy Group for Adolescents with Type 1 Diabetes: A Pilot Study 
 
Please initial each box: 
 
I confirm that I have read and understood the information sheet for the above study and I 
have been given the opportunity to ask any questions I might have. 
 
I understand that I do not have to take part in this study. It is my choice and I can stop at any 
time, without giving a reason and this will not affect any aspect of my care. 
 
I understand that all information will be confidential and there will be nothing to identify me 
as having taken part in the study. 
 
I agree to keep all information discussed within the group confidential. 
 
I agree to take part in the above study. 
 
Name: __________________________________________________________ 
 
Signature: _______________________________________________________ 
 
 
Name of Researcher: _______________________________________________ 
 
Signature of Researcher: ____________________________________________ 
 
Date: ____________________________ 
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Appendix 2.11: Problem Areas in Diabetes-Teen Version (PAID-T) 
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Appendix 2.12: Self-Efficacy for Diabetes Scale  
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Appendix 2.13 Individual participant scores pre- and post- intervention.  
 
Figure 1A. Individual HbA1c scores for pre- (    ) and post- (    ) intervention for participants in the 
control group  
 
 
Figure 1B. Individual HbA1c scores for pre- (    ) and post- (    ) intervention for participants in the 
intervention group 
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Figure 2A. Individual PAID-T scores for pre- (    ) and post- (    ) intervention for participants in the 
control group 
 
 
Figure 2B. Individual PAID-T scores for pre- (    ) and post- (    ) intervention for participants in the 
intervention group 
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Figure 3A. Individual Self-Efficacy scores for pre- (    ) and post- (    ) intervention for participants in 
the control group 
 
 
Figure 3B. Individual Self-Efficacy scores for pre- (    ) and post- (    ) intervention for participants in 
the intervention group. 
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Appendix 2.14: Semi-Structured Interview Schedule 
 
1. What made you decide to agree to attend the group? 
 
2. How did you feel before you came to the group? Did you have any worries or 
concerns about being involved? 
 
3. How did you feel after the group?  
 
4. What do you remember in particular about the group? 
 
5. What did you think was the best thing about the group? 
 
6. Has the group made you think differently about having diabetes? In what way? 
 
7. Have you made any changes to the way you manage your diabetes since the group?  
 
8. Do you think it was good to just have a one off group or would you have preferred to 
attend for a number of group sessions? 
 
9. What was it like listening to and hearing from the experienced patients? 
 
10. How old do you think the experienced patients should be? Does age matter? 
 
11. Would you recommend the group to other teenagers? How you think we could 
encourage more teenagers to participate in a group like this? 
 
12. How do you think we could make the group better? 
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Appendix 2.15: Example of Interview Extract and Coding 
TRANSCRIPTION EXTRACT CODING/NOTES 
I: What made you decide to take part in the group?  
P: After I read all the information I was given I talked 
it through with my mum and we thought it would be 
a good idea, just to see what it was like and em it 
just sounded good 
 
Parental influence? 
I: How were you feeling before you came to the 
group? Were you worried or nervous? 
 
P: Yeah I was nervous because I wasn’t sure what 
was going to happen but once I got there it was fine, 
it was relaxing 
Apprehension, Nervous 
Relief? 
I: What were your thoughts and worries about 
coming along? 
 
P: Just what was going to be asked and what 
everyone was going to be like 
Uncertainty, apprehension, peer reactions? 
I: How did you feel after the group?  
P: It felt really good, I felt like I learnt a lot of stuff 
and it was reassuring to know I was not the only 
person who went through what I have been through, 
there were other people who have been through 
what I have been through 
Reassuring 
Relief 
Others have been through similar things 
Shared understanding 
I:  What do you remember in particular about the 
group? 
 
P: Just everyone telling their stories and how they 
all went through rough patches and rebellious years 
and I can kind of sympathise with that because I did 
the same thing 
Others stories 
Difficulties and rebellion 
Similar situations-high levels of sympathy and 
empathy 
I:  What do you think was the best thing about the 
group? 
 
P: Just hearing each individual stories and just 
knowing you are not alone and just knowing that 
there is someone else out there because sometimes 
you can feel isolated, so it was just good hearing 
everyone’s stories 
Not being alone 
Feeling less isolated 
Shared understanding of what it is like to have 
diabetes  
I: Has the group made you think differently about 
your diabetes? 
 
P: Yeah cause a couple of the stories I was quite 
shocked as they let it get so bad and em they put 
themselves in danger but I didn’t want to do that so 
it kind of made me wisen up. 
Wake up call- shock  
Wise-up 
I:  Do you think it has made you change anything 
about the way you try to manage your diabetes? 
 
P:  Yeah I am eating better, I am doing more 
exercise and I am just making better choices about 
my diabetes 
Rethink ways of managing condition  
Change in self-management?  
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Appendix 2.16: Major Research Proposal  
Abstract 
Background 
Diabetes is the third most common chronic illness in childhood following asthma and 
cerebral palsy (Jones, 2002). During adolescence, metabolic control can often worsen and if 
not addressed can lead to significant long term health consequences (Dabadghao et al, 
2001). Educational group approaches to working with adolescents with diabetes have 
indicated beneficial effects in relation to management outcomes (Hampson et al, 2001). 
There has however been criticism that programmes such as the expert patient programme 
has tended to attract those who are already good self-managers of their diabetes and thus 
was failing to reach those people who might benefit the most from intervention (Kennedy, 
2005). 
A novel group approach drawing on narrative therapy was undertaken at the University 
College London Hospital to work with adolescents in an inpatient service presenting with 
symptoms of pain and fatigue (Christie, D et al, unpublished). This narrative approach 
involved a one off workshop utilising outsider witnesses to explore the lived experiences of 
these individuals and reflect on both the challenges they face and the values and skills that 
they have.  
Aims 
The aim of the present research study is evaluate the feasibility of a narrative therapy group 
workshop for adolescents who are struggling to control their diabetes.  
Methods 
A total of 15 adolescents and 15 controls will be recruited through Royal Hospital for Sick 
Children (RHSC). This will be a quantitative study which will evaluate the effectiveness of a 
group approach by assessing self-efficacy, diabetes related emotional distress and HbA1c 
levels in participants both prior to and after the intervention.  The acceptability of the 
approach will be measured via an evaluation questionnaire and through a semi structured 
interview with participants following the group.  
Applications 
The research will be aimed at those who are struggling most to manage their diabetes. The 
primary purpose of this study is to assess whether or not a narrative therapy group approach 
for adolescents is a feasible and acceptable addition to their current treatment. The 
consequences of poor management of diabetes have been widely documented and 
therefore there is a value to exploring the role of psychological therapy in improving both the 
short term and long term outcomes for this population. Overall, this study will add to the 
evidence base for psychological interventions for adolescents with Type 1 diabetes.  
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Introduction 
Diabetes in Adolescence 
Diabetes is the third most common chronic illness in childhood following asthma and 
cerebral palsy (Jones, 2002). It can be extremely difficult to manage as patients must learn 
how to maintain the balance between insulin dosage, diet and activity (Waller, 2004). 
Furthermore, during adolescence, metabolic control worsens and if not addressed, can lead 
to significant long term health consequences (Dabadghao et al, 2001). During this period of 
transition from childhood to adolescence, peer relationships become central to the 
individual’s sense of identity. For those with a diagnosis of diabetes the restrictions placed 
upon them can impact on their sense of belonging within a peer group and as a result some 
will go on to neglect health regimes and self care in favour of peer group acceptance 
(Kyngas et al, 1998). 
Adjustment and Adherence Issues 
Malik and Koot (2009) endeavoured to understand and explain adjustment in adolescents 
with type 1 diabetes. They found that both diabetes related stress and general stress were 
critical predictors of adjustment within this population. They also revealed that diabetes 
related stress could potentially displace the effects of protective factors and thus could play a 
central role in the development of maladjustment in adolescents with Type 1 diabetes. In 
addition, diabetes related stress was found to fully mediate the relationship between 
metabolic control and quality of life and wellbeing. The authors emphases the value of 
targeting diabetes related distress in clinical interventions.  
Current psychological treatment of diabetes 
Individuals with type I diabetes are usually managed on an outpatient basis and receive 
input from a medical consultant, specialist nurse and a dietician (Hampson et al, 2001). In 
addition to the medical management of diabetes, there are recommendations that 
educational and psychosocial interventions should also be offered as an integral part of 
diabetes care (Gage et al, 2004). There is a growing awareness of the importance of 
identifying effective psychological interventions that can help to optimise both glycemic 
control and quality of life particularly during the transitional period of adolescence (Gage et al, 
2004 & Van der Ven, 2003). 
A systematic review of educational and psychosocial interventions with adolescents with 
Type I diabetes was undertaken by Hampson et al, (2001). A total of 62 studies were 
included for evaluation. 25 of these studies were randomised controlled studies and effect 
sizes were calculated for 14 of these. The results indicated small to medium effect sizes for 
these interventions. A narrative review of 21 pre-post studies with no control group was 
performed. All of the studies reported beneficial effects of the group approaches in relation to 
diabetes management outcomes. The authors highlighted that very few of these studies 
addressed the economic considerations of running such groups. They acknowledged 
however, that targeting poorly controlled individuals may reduce hospitalisations and future 
complications and as a result would prove to be more cost effective than generic 
interventions (Hampson et al, 2001). 
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Expert Patients 
In 2001 the Department of Health published a document entitled “The expert patient: a new 
approach to chronic disease management for the 21st century”. The key theme from this 
document was that patients are experts in managing their disease and have a considerable 
amount to contribute to the treatment process.  One key example of this was the introduction 
of self management programmes which were envisaged to help reduce severity of 
symptoms and improve confidence, resourcefulness and self efficacy of those living with 
chronic illness (Tattersall 2002).  
The chronic disease self management programme was initially developed in the USA and 
has since been adopted by a number of countries including the UK. Within the UK this has 
become known as the “Expert Patient Programme”. The UK concept of expert patient 
derives from the assumption that individuals affected by chronic illness are likely to develop 
expertise in managing their condition and this expertise is likely to be very different in nature 
to the knowledge of health professionals (Wilson et al, 2007). 
The expert patient programme is modelled on the work of Kate Lorig who established the 
chronic disease management programme in the USA. This programme consists of 6 
consecutive sessions of 2.5 hours each. These programmes are led by trained individuals 
who are living with chronic illness. Initially, the programmes were offered as generic courses 
open to anyone living with any form of chronic illness (Wilson et al, 2007).  Whilst this format 
of the course was valued by some, evidence was emerging that there was a need for 
condition specific courses particularly for those living with diabetes (Kennedy, 2005). 
Evaluation of the Expert Patient programme reported that EPP provided patients with 
moderate gains in self efficacy, improvements in quality of life and gains in secondary 
outcomes including psychological wellbeing (Kennedy, 2007). However EPP was criticised 
due to the fact that it appeared to be attracting those who were already good self -managers 
and was failing to reach those people who might benefit the most (Kennedy, 2005). 
Narrative Approaches 
In recent years, patient education for the self management of diabetes and other chronic 
diseases has undergone considerable changes. It is no longer enough to offer directive and 
informative education. We have become more aware that adopting healthy habits depends 
less on information and skills and more on personal intrinsic motivation to make and sustain 
changes (Piana et al, 2010). It is therefore important to think of creative and alternative ways 
to engage with teenagers to increase their motivation to improve their diabetic control and to 
help them to make sense of their illness.  
Many of the concepts of narrative therapy were introduced by Epson and White and 
encapsulate many different therapeutic themes. In essence, narrative therapy promotes the 
belief that people are experts in their own lives. It views problems as separate from people 
and assumes that people have many skills, competencies, beliefs, values and abilities that 
will assist them to reduce the influence the problem has over their lives (Morgan, 2000). 
Underlying Narrative therapy is the premise that as humans we are always seeking ways of 
interpreting our world. In doing this, we create stories about ourselves and others and these 
then influence the way we lead our lives. Hearing the way in which a person tells their story 
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provides valuable information about how that individual makes sense of their situation and 
the limitations these can place upon them.  
Piana et al (2010) evaluated the effects of a narrative-autobiographical approach on 
adolescents with Type I diabetes. Outcomes included self awareness, concern for self care 
and well being. The approach was underpinned by a narrative perspective which posits that 
in order to cope with an illness such as diabetes the individual must understand the 
experience of being ill whilst also finding and assigning meaning to their condition. Indeed, 
individuals must realise and reinterpret the story of their world and their life in order to 
increase coping and improve outcomes (Good & Del Vecchio, 1994). Ninety four 
adolescents with Type I diabetes who attended a nine day summer camp participated in 
structured daily self writing proposals on diabetes, integrated with daily interactive self 
management education. Follow up questionnaires allowed for feedback to be obtained on 
this therapeutic approach. Qualitative research revealed that writing about the discovery of 
diabetes had been a very liberating effect and had resulted in the change of perception of 
self, in relationships with others and n the relationship with the disease. The authors 
conclude that this approach helped adolescents to overcome their feelings of diversity and 
isolation whilst increasing their self efficacy, acceptance of diabetes as well as their sense of 
responsibility in self management (Piana et al, 2010). 
 
Background and rationale for present study 
A novel group approach drawing on narrative therapy has been undertaken at the University 
College London Hospital to work with adolescents in an inpatient service presenting with 
symptoms of pain and fatigue (Christie, D et al., unpublished). The authors conducted a one 
off workshop lasting approximately 2 hours. A total of 8 participants were included. Four of 
these were current patients within the ward and the remaining 4 were individuals who had 
previously been inpatients but whom were now managing to cope with the symptoms more 
effectively. These individuals were known as “experienced consultants” and were included 
within the group to act as outsider witnesses.  
The four experienced consultants were people who had been in a similar situation to those 
presently on the ward but who were now further along their journey. They had previous 
personal experience of what it is like to struggle with the challenges facing the inpatients and 
had “expert” knowledge about how to tackle many of the difficulties the adolescents were 
facing. They were therefore in a unique position to fulfil this role.  
As in the practice of narrative therapy, outsider witnesses are often invited as an audience to 
a therapy conversation. Outsider witnesses may or may not be known to the individuals 
within the group and can also vary on their level of knowledge and experience about the 
therapeutic issue being addressed. The outsider witness role is to listen to the individuals 
preferred stories or ways of living and helps to reflect what they hear.  
The findings from this small research project reported positive outcomes for those individuals 
within the inpatient ward. This included physical progress, attitudes to their illness and also 
family reports of their wellbeing were improved (Peer Communication, 2010). 
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The present research aims to replicate their approach with an adolescent diabetes 
population to explore whether a similar group could have a positive effect on those who are 
struggling to manage and control their diabetes.  
Aims  
The current study is a pilot study which aims to assess the feasibility of conducting a larger 
controlled trial of this narrative therapy group approach with adolescents with Type 1 
diabetes. Specifically the pilot will aim to: 
3. Assess if a larger controlled study would be warranted 
4. Inform the design of future studies in terms of the “PICO” requirements (SIGN 50): 
e) Target Population: Confirm the eligibility and suitability of individuals who are likely 
to benefit from the treatment 
f) Intervention: Identify any modifications required to the narrative therapy group 
approach 
g) Control group: provide detailed information on what treatment as usual involves 
h) Outcomes: confirm which outcomes may be appropriate to target in future 
interventions 
5. In addition, the study will aim to provide information which will help to inform sample 
size requirements for future studies.  
Research Questions 
 What are the potential numbers of participants who fulfil eligibility criteria? 
 What proportion of potential participants consent to participate in a narrative therapy 
group approach? 
 Does participation in the narrative therapy group reduce diabetes related distress as 
measured by the Problem Areas in Diabetes-Teen Version? 
 Does participation in the narrative therapy group approach increases self efficacy 
within this population as measured by the Self Efficacy for Diabetes Scale? 
 Does participation in the narrative therapy group have any effects on future HbA1c 
levels recorded at their next clinic appointment(s)? 
 Do participants within the narrative group report the intervention to be an acceptable 
addition to their treatment as usual and what modifications may be required for future 
studies? 
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Plan of investigation 
Participants 
15 adolescents aged 12-15 with Type 1 diabetes will be recruited from RHSC.  The 
adolescents will have been struggling to manage their diabetes for the past 8 months; this 
will be defined as an HbA1c level of > 8% at their last two clinic appointments. 
2 experienced patients aged 17 and over who have previously struggled to manage their 
diabetes but who now have good control will be invited to attend the groups as outsider 
witnesses.  The term “experienced patient” was favoured over “experienced consultant” after 
consultation with the diabetes team at RHSC.  
Control Group 
15 adolescents aged 12-15 with Type 1 diabetes who have been struggling their diabetes for 
over 8 months, again this will be defined as an HbA1c level of >8% for the past 8 months. 
The control group will be asked to complete the two questionnaires at similar time intervals 
to those who attend the group. The control group will not however attend the narrative group 
approach but will receive treatment as usual. If the group is deemed to show positive results 
then the control group will be invited to attend future groups which will be run by the Clinical 
Psychologist involved in the present study.  
 Inclusion criteria for participants 
 Aged 12-15 
 Have had a diagnosis of Diabetes for at least a year 
 Are not receiving current psychological input from RHSC 
 No known learning disability 
 English as their first language 
 HbA1c > 8% for at least 8 months 
 Currently attending diabetes clinic for Type 1 diabetes within RHSC 
 Written consent provided by both participant and their parent/guardian 
Inclusion criteria for experienced patients 
 Aged 17 and over 
 No known learning disability 
 English as their first language 
 Previously had HbA1c > 8% for at least 8 months 
 Has been managing to control their Type 1 diabetes for at least 1 year 
 Written consent provided by both participant and their parent/guardian 
 
Inclusion criteria for control group 
 Aged 12-15 
 Have had a diagnosis of Diabetes for at least a year 
 Are not receiving current psychological input from RHSC 
 No known learning disability 
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 English as their first language 
 HbA1c >8% for at least 8 months 
 Currently attending a diabetes clinic within RHSC  
 
Recruitment process 
The principal researcher will liaise with the diabetes nurses at RHSC to identify suitable 
participants and experienced patients. Once ethical approval has been granted, information 
sheets will be sent to those who meet the inclusion criteria via the nursing team at RHSC.  
Potential participants will be asked to complete an opt-in form indicating whether they would 
be interested in being involved in the research. At this point they will be made aware that this 
may involve attending the intervention group or completing questionnaires as part of the 
control group.  
Once an adequate number of participants have agreed to take part, individuals will be 
randomly allocated to either the intervention group or the control group and written consent 
will be obtained from the adolescent and their parent/guardian.The consent forms will be 
sent to all of those who have opted in to the research and these sheets will be also sent out 
via the nursing team at RHSC.  
In total, 3 intervention groups will be run. Each group will be made up of 5 adolescent 
participants and two experienced patients. Participants will be provided with a minimum of 2 
weeks notice before the group.  
Potential experienced patients will be approached by either their direct health care team or 
by the Clinical Psychologist working within RHSC. These individuals will be identified jointly 
by the nurses at RHSC and those working within the transition teams at either Victoria 
Infirmary or Stobhill Hospital in Glasgow. Potential experienced patients will be provided with 
an information sheet and an opt-in form which they will be asked to complete if they are 
willing to be involved in the research.  At this point, a consent sheet will be sent out to those 
who have opted in and potential participants will be asked to provide written consent to take 
part. As these individuals will be 17 or older, parental consent will not be required.  
Measures 
HbA1c which is routinely measured in the clinic will provide information on patients levels of 
diabetic control both pre and post intervention.    
Participants will be asked to complete 2 short questionnaires prior to starting the group, and 
at 3 month follow up. The questionnaires to be used are titled below: 
 Problem areas in Diabetes-Teen Version (Weissberg-Benchell, J, In press) 
 Self Efficacy for Diabetes scale (Stanford Patient Education Research Centre) 
 
 A short evaluation questionnaire (designed by the research team) will allow for 
participants to provide feedback on their experience of the group. This will help to 
determine the acceptability of this approach for adolescents with diabetes.  
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Design 
This will be an exploratory pilot study using a quantitative and qualitative approach.  The 
study will seek to compare the outcomes for those who attend the narrative group approach 
and those who receive treatment as usual. Data will be obtained from the questionnaires and 
from the Hb1Ac measures both prior to the group starting and at a specified follow up period 
(3 months for questionnaires and next clinic appointment(s) for HbA1c). Qualitative 
information on acceptability of the group will be gathered through an evaluation 
questionnaire immediately following the group and by a short semi structured interview 
approximately 3 months following the group. 
Procedure 
Prior to the groups starting, participants will be asked to complete the agreed questionnaires 
as a baseline measure. In addition, the control group will be asked to complete these 
baseline measures at approximately the same time as the intervention group.  
The 3 groups will be facilitated by Researcher VW and a qualified Clinical Psychologist. In 
order to keep the ratio of experienced consultants to group participants similar to that of 
Christie et al. (unpublished), the groups will each consist of 5 adolescent participants and 2 
experienced patients.  
Initially, participants will be invited to introduce themselves to the other members and the 
format of the session will be explained.  
The group will be facilitated in accordance with White’s (2007) recommendations on 
involving outsider witnesses within therapeutic interactions. The group will therefore be 
divided into three distinct phases:  
1. The telling of the significant story by each person in the group 
2. The retelling of each story by the people invited to be outsider witnesses 
3. The retelling of the outsider witnesses’ retelling which is done by the 
adolescent’s for whom the group is for. 
 
The process of retelling will involve four key stages; identifying the expression, describing 
the image, embodying responses, acknowledging transport.  
1. Expression 
 
The individual will be asked to speak about what they heard that they were most drawn to, 
what caught their attention and captured their imagination.  
 
2. Focus on the Image 
They will then be asked to describe ant image or mental pictures that came to their mind as 
they listened to the stories. At this point the outsider witnesses will be encouraged to reflect 
on how this information influences their views on the person’s values, beliefs, hopes, 
aspirations, dreams and commitments.  
3. Personal Resonance 
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The outsider witness will then be encouraged to provide some account of why they were so 
drawn to certain expressions with a specific focus on their understanding of the way these 
expressions struck a chord with their own personal history.  
4. Transport 
 
The therapist will then invite the outsider witness to speak of the ways in which they have 
been moved on account of being present to witness these stories. Questions about where 
the experience has taken them with regard to their own thoughts and their understanding of 
their own life experiences will be elicited.  
 
The psychologist and the principal researcher will interview the adolescent experienced 
patients within the group about their experiences of living with diabetes. The other 
participants will then be asked to reflect on what was said to the whole group.  Following this, 
the psychologist and principal researcher will interview the participants within the group and 
the experienced patients will be asked to reflect on what was discussed.  The group will be 
structured using the format discussed above, it will be important for the research team to 
ensure that the language used and the way in which the group is facilitated is appropriate to 
the age and cognitive level of the group participants.  
Immediately following the group, participants will be asked to complete a short evaluation 
questionnaire on their experience of attending the group. This will help to determine how 
acceptable the group was deemed to be by this population.  
Follow up questionnaires will be completed at 3 month follow up. In addition, their HbA1c 
levels at their next clinic appointment(s) will be passed on to the principal researcher.  
Approximately 3 months after the participants have attended the group, they will be invited to 
participate in a follow up semi structured interview. This will allow them to provide their views 
on attending the group. Additional consent will be gained from the adolescents and their 
parents to participate in these follow up interviews.  
Justification of Sample Size 
Owing to the unique nature of this pilot study, a calculation of a predetermined sample size 
was not deemed to be appropriate. However, the study aims to recruit a total of 30 
participants who will be randomised to either the narrative therapy group (intervention) or 
treatment as usual (control).  
Following the period of data collection, the principal researcher will conduct post hoc effect 
size calculations which will help to inform future studies in this area. 
Setting and equipment 
The group will be carried out in a room at RHSC.  It is envisaged that this will take place 
from 3pm to 5pm to ensure minimal disruption to the school routine. 
Data analysis 
The present research aims to provide a comparative study of outcomes following a narrative 
group approach.  
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As this study will be collecting both within subject and between subject data a Two Way 
Mixed ANOVA will be used to analyse the data. This method of analysis will be used to 
consider any changes in diabetes related distress, self efficacy and HbA1c measures of the 
group participants following the group.  Non parametric alternatives can be utilised if the data 
does not meet the statistical assumptions required for the ANOVA.  
Health and safety issues 
Researcher safety issues 
The group will be conducted in room at RHSC and will be facilitated by the Researcher VW 
and a qualified Clinical Psychologist. When the group is being run other hospital staff will be 
nearby and available if required. 
Participant safety issues 
Written consent will be obtained from all participants (including the experienced patients) 
and their parents/guardians.  They will be informed that they are able to withdraw their 
consent at any point during the study.  All data will be anonymised to ensure confidentiality. 
Prior to the group starting participants will be informed that anything discussed in the group 
will remain confidential unless the facilitators feel that there is a risk to themselves or to 
others.  If any psychological concerns arise during the group participants will be offered the 
opportunity to be referred to the Psychology Service at RHSC. This will also be available to 
the experienced patients.  
The principal researcher will ensure that they have with them glucagon and high glycaemic 
carbohydrate snacks in the event that a participant was to display signs of being 
hypoglycaemic.  
Ethical issues 
Ethical approval will be sought from the West of Scotland Research Ethics Committee and 
from Greater Glasgow and Clyde Research and Development team. In addition, the project 
will be sent to Research and Development in Ayrshire and Arran as the principal researcher 
is an Ayrshire Trainee.  
Financial Costs 
These are outlined within the “Research Equipment, Consumables and Expenses” form 
completed alongside this proposal.  
Timetable  
May 2011 Submit proposal to University 
June/July 2011 Proposal assessed 
August 2011 Apply for ethical approval 
November 2011 Begin recruitment 
February/March 2012 Analysis and follow ups 
April-June 2012 Write up research 
July 2012 Submit research to University 
September 2012 Viva  
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Practical Implications of research 
The research will be aimed at those who are struggling most to manage their diabetes. The 
primary purpose of this study is to assess whether or not a narrative therapy group approach 
for adolescents is a feasible and acceptable addition to their current treatment. The 
consequences of poor management of diabetes have been widely documented and 
therefore there is a value to exploring the role of psychological therapy in improving both the 
short term and long term outcomes for this population. Overall, this study will add to the 
evidence base for psychological interventions for adolescents with Type 1 diabetes.  
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